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7 Abstract 
Myosin VI (MVI) is implicated in many biological processes including, cell migration, 
endocytosis and transcription. MVI achieves its plethora of cellular functions owing 
to its association with multiple binding partners. Here, two proteins associated with 
MVI – nuclear dot protein 52 (NDP52), a putative transcription regulator, and the 
established transcription factor, oestrogen receptor (ERα) – are biochemically and 
biophysically characterised to further elucidate the role of this motor protein in 
transcription. Optimisation of expression and purification conditions has enabled the 
successful purification of full-length ERα using BL21 E.coli. According to current 
literature, this is the first time this has been reported. This will set the foundation for 
future purification optimisation required for binding assays between MVI and ERα. 
NDP52 has only recently been characterised as a putative transcription co-activator, 
where it was shown to promote RNA polymerase II (RNAPII) transcription by relieving 
the auto-inhibition of MVI. Here, novel insights into the biochemical and biophysical 
properties of NDP52 are presented, including DNA-binding characteristics of 
different structural domains using fluorescence-based binding assays. Expectedly, C-
terminal DNA-binding motifs likely confer binding to double-stranded DNA (dsDNA) 
in vivo. Small-angle X-ray scattering (SAXS) data for full-length NDP52 is also 
presented, providing important structural information, given that no full-length 
crystal structure for NDP52 is currently available. Methods such as total internal 
reflection fluorescence (TIRF) microscopy, size-exclusion chromatography-multi-
angle light scattering (SEC-MALS) and cryogenic super-resolution microscopy have 
also provided an understanding of the oligomeric state of NDP52 and its tertiary 
structure. Together, this evidence suggests that NDP52 functions as a parallel 
homodimer in vivo, which provides important structure-function insights into 
NDP52’s role in transcriptional regulation. For instance, the parallel arrangement of 
the NDP52 dimer may facilitate tight binding to dsDNA, where each monomer binds 
either side of DNA, effectively clamping it. 
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8 Introduction  
8.1 Myosins are actin-based molecular motors 
Kinesin, dynein and myosin constitute the 3 classes of cytoskeletal molecular motors, 
converting chemical energy from the hydrolysis of ATP into mechanical energy.1 The 
myosin superfamily is diverse and categorised into 35 distinct subclasses2, including 
conventional and non-conventional myosins. Together, these perform a variety of 
functions such as muscle contraction3, cell division4 and endocytosis5 to name but a 
few.  
Structurally, myosins are classified according to their C-terminal tail domain, which, 
unlike the N-terminal motor domain, is highly divergent (Figure 1) and permits 
different biological functions by binding to different cargo6 and associated regulatory 
proteins7. The N-terminal ATPase domain of myosin heavy chains, also known as the 
‘motor domain’ or ‘head’, is highly conserved in evolution owing to its ability to bind 
both actin and ATP (Figure 1A).8 Myosin heavy chains are also characterised by a neck 
region (also known as the ‘lever arm’), which consists of varying numbers of 
isoleucine-glutamate (IQ) motifs (from 1-6) depending on the class (Figure 1A).6 IQ 
motifs conventionally facilitate binding to calmodulin/myosin light chains.6,9 Myosin 
VI (MVI) has 2 calmodulin binding sites – an IQ motif and insert-2.10  
The lever arm of myosins is so called since it is believed to transduce force and 
movement from the N-terminal head, during the ATPase cycle, to the C-terminal tail; 
hence, acting as a lever or converter.11 Binding of calmodulin to IQ motifs in the lever 
arm provides rigidity and structural support to this otherwise long and flexible 
protein domain, which enables walking along actin filaments.12 Many myosins 
conform to the lever arm hypothesis, which predicts that myosin step size is directly 
proportional to the length of the lever arm.11 Although, some challenge it. For 
instance, experiments using optical tweezers have demonstrated that MVI takes a 
larger step size (on average between 30-36nm) than expected, considering its 
relatively short lever arm with only 2 IQ motifs.13
Hannah Reed 17 
 
 
Figure 1: Myosin superfamily structure 
(A) Schematic of myosin structural domains. All myosins have 3 key structural elements: a N-terminal motor domain, a neck region and a C-terminal tail 
domain. Depending on the myosin class, there will be varying numbers of IQ motifs in the neck region.6 (B) Comparison of a conventional and unconventional 
myosin structure. Myosin II is well-characterised in muscle contraction, where it provides the power to facilitate the sliding filament mode of muscle 
contraction.14,15 Myosin II is the only conventional class, while all other myosins are termed ‘non-conventional’.6 Coiled-coil motifs in the tails of some myosin 
classes are believed to facilitate dimerisation.6 Myosin VI, for example, can exist in both a monomeric or dimeric form, which is mediated by binding 
partners16,17, whilst myosin II is only ever monomeric6. Myosins can contain other structural domains, such as 4.1, ezrin, radixin and moesin (FERM) domains, 
which enable binding to transmembrane proteins and are found in myosins such as myosin VIIa and X.6 Myosin VI has unique amino acid sequences, labelled 
insert-1 and -2, which are discussed in text. Other myosin classes are not shown. Figure re-drawn from Krendel & Mooseker, 2005. 
A
Conserved Motor/Head Domain Neck Region Divergent Tail Domain
B
Conventional Myosin - Myosin II
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8.2 Myosin VI demonstrates unique directionality and a plethora of 
biological functions  
Actin filaments are orientated so that their barbed (positive) end points towards the 
plasma membrane, while the pointed (minus) end faces away from the plasma 
membrane towards the nucleus.18 MVI, unlike other myosins, displays unique 
directionality, walking towards the minus end of actin filaments.19,20 
Repositioning/reversal of the lever arm by 120° is achieved in MVI by a unique 53-
amino acid insert (insert-2) between the motor domain and IQ motif in the neck of 
the protein (Figure 2A).21 It is this repositioning of the lever arm which is responsible 
for the unique directionality of MVI.21 
 
Figure 2: Myosin VI structure 
(A) Schematic of myosin VI structural domains. Key structural domains of myosin VI include: 
the N-terminal motor domain, insert-2 (discussed in text) which can bind Ca2+-calmodulin21, 
another calmodulin-binding IQ motif and the tail domain. The tail domain can be split into 
the proximal tail/lever arm extension, medial tail, distal tail and C-terminal cargo-binding 
domain.16 The lever arm extension contains a 3-helix bundle thought to help facilitate the 
large step-size of myosin VI dimers upon unfolding (although remains a topic of 
controversy)22, while the medial tail contains a short coiled-coil and then single α-helix16. 
Figure largely inspired by Phichith et al, 2009. (B) Crystal structure (ribbon diagram) of 
nucleotide-free myosin VI. The N-terminal motor domain of myosin VI comprises the N-
terminal, U50, L50 and converter domains.21 The Src homology domain 3 (SH3) of myosin VI 
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The unique directionality of MVI suggests that it may have important biological 
functions, which has been the driving force behind research in the Toseland 
laboratory, as well as many others. This is in fact true, as MVI is implicated in 
transcription (along with nuclear myosin I and myosin Vb).23 The range of functions 
of MVI is commonly attributed to its splice isoforms and range of binding partners, 
which will be discussed below. To give an overview of the range of biological 
processes MVI is implicated in, MVI has functional roles in both clathrin-coated and 
non-clathrin coated vesicle endocytosis, hearing through maintenance of stereocilia, 
autophagy, cell migration, cytokinesis, synaptic transmission, maintenance of Golgi 
morphology and the secretory pathway (Figure 3).24 
MVI is alternatively spliced resulting in the so-called ‘large insert’ (LI) and ‘small 
insert’ (SI) isoforms, where there are 31-residue and 8-residue insertions before and 
in the cargo-binding domain (CBD) respectively.7,25 In combination, these inserts 
result in the SI+LI isoform. These isoforms have distinct distributions, where the non-
insert (NI) isoform can enter the nucleus whilst the LI isoform cannot.7 MVI isoforms 
are also believed to be selective for different binding partners, where NDP52 has 
been shown to bind and regulate the backfolding of the NI isoform7 (Figure 7A), 
whilst the LI isoform can only bind partners at the WWY motif (excludes NDP52)25. 
Hence, splice isoforms of MVI contribute to its range of biological functions.  
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Figure 3: Myosin VI has a range of biological functions thanks to multiple binding partners 
Myosin VI has many biological functions owing to its range of binding partners, as shown, 
including maintaining stereocilia morphology and autophagy (discussed in text). Myosin VI 
also functions in synaptic transmission, such as glutamergic transmission26, through its 
interaction with a-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA)–type 
glutamate receptors via synapse-associated protein 97 (SAP97)27. Figure taken directly from 
Tumbarello et al, 2013. 
As discussed, MVI, along with nuclear myosin I (NM1) and myosin Vb, is implicated 
in transcription.23 Using chromatin immunoprecipitation (ChIP), MVI has been shown 
to be recruited to the promoters of actively transcribed genes.28 MVI has also been 
shown to complex with RNA polymerase (RNAP) II upon transcription activation 
through immunoprecipitation assays and immunofluorescence.28 Expression levels 
of MVI also correlate with RNAPII-mediated transcription.28 Recently, MVI has been 
further characterised in transcription, where it was shown to co-localise with 
transcriptionally active regions upon PC12 cell stimulation.29 Many MVI binding 
partners are also thought to be implicated in processes associated with gene 
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expression, such as heterogeneous nuclear ribonucleoprotein U (hnRNPU) 
implicated in pre-mRNA metabolism and transport29, as well as nuclear dot protein 
52 (NDP52) and oestrogen receptor α (ERα) – which are transcriptional regulators7.  
ERα has only recently been characterised as a MVI binding partner7 but has long been 
recognised as a nuclear receptor transcription factor30. NDP52, however, has only 
recently been characterised as a putative transcription factor7 but is well-
characterised as a MVI binding partner31. These MVI binding partners are of great 
interest with regard to MVI’s role in transcriptional regulation, which will be 
discussed in the following chapters.    
8.3 Overview of transcriptional regulation 
There are 3 RNA polymerases (RNAPs) in eukaryotes, where RNAPI, II and II transcribe 
class I, II and III genes respectively. RNAPII is also responsible for the transcription of 
mRNA, in addition to class II genes, and hence is a key regulator of eukaryotic gene 
expression. RNAPII is a formed of 12 distinct subunits, where RNA-binding protein 
(RBP) 5, 6, 8, 10 and 12 are common to the 3 classes of eukaryotic RNA 
polymerases.32 These 12 subunits must come together in a coordinated fashion to 
enable transcription of class II genes.33 General transcription factors (GTFs) that 
mediate this assembly are TFIID, TFIIB, TFIIF, TFIIE and TFIIH, which assemble in this 
order.33 GTFs have roles in promoter recognition, RNAPII recruitment and 
transcription start site (TSS) recognition, where TFIIH specifically has helicase and 
kinase roles.33 
Transcription is divided into 3 stages: initiation, elongation and termination. The C-
terminal domain (CTD) of RBP1 (largest subunit of RNAPII) acts as a binding scaffold 
for nuclear factors, regulated by phosphorylation events at Ser2 and 5.33 
Phosphorylation of Ser2 and 5, of the tandemly repeated heptad sequence 
(YSPTSPS), is particularly important during the transition between initiation and 
elongation, as well as during transcription termination.33 This CTD is therefore an 
important regulatory domain in RNAPII. 
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The term ‘transcription factor’ refers to any protein that can bind DNA in a sequence-
specific manner and regulate transcription.34 The diversity of transcription factors is 
vast, which is expected considering that they account for approximately 8% of all 
human genes.34 Transcription factors achieve transcriptional regulation through 
chromatin remodelling, via histone acetylation/deacetylation, interactions with co-
factors and directly by recruiting RNAPII to the promoters of target genes.34  
Transcription factors and transcription factor binding proteins are implicated in many 
human diseases, including cancer and asthma. For instance, pro-inflammatory gene 
expression, regulated by transcription co-activators such as nuclear factor-κβ (NF-κβ) 
and activator protein-1 (AP-1), is enhanced in chronic inflammation.35 Actions of 
these transcription co-activators results in the acetylation of core histones, hence 
promoting transcription of pro-inflammatory genes.35 Corticosteroids are an anti-
inflammatory therapy used to effectively treat asthma but are relatively ineffective 
for chronic obstructive pulmonary disease (COPD), where they act by reversing this 
histone acetylation.35 Similarly, mutations in transcription factors are often 
implicated in cancer, such as those in N-MYC36 and ERα30.   
Transcription factors are usually divided into 2 classes – co-activators and repressors 
– which respectively promote or repress transcription. Transcription factors are 
usually modular in structure, containing a DNA-binding domain, as well as either an 
activator or repressor domain connected by a flexible linker.37 These domains are 
believed to act independently of each other, as demonstrated initially with GAL4.38 
Repressor domains usually have high proportions of hydrophobic amino acid 
residues, while activator domains exhibit large structural diversity.37  
Well-characterised DNA binding motifs in transcription factors include zinc fingers 
(ZFs) and basic leucine zippers (LZs).37 Zinc fingers, as the name suggests, coordinate 
1 or more Zn2+ ions via cysteine and histidine residues, where the structure formed 
enables insertion into the major groove of DNA.37 There are different classes of ZFs, 
including the C2H2, C4 and C6 classes, where the C2H2 class is one of the most common 
found in eukaryotic transcription factors.37 Leucine zippers, however, are 
characterised by leucine at every 7th position; since most transcription factors with 
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these domains are dimeric, this motif forms a zipper-like structure.37 Other DNA-
binding motifs include homeodomains and helix-loop-helix motifs.37 
8.4 Myosin VI transcriptional regulation extends beyond androgen 
receptors  
ERα and ERβ both belong to the class of steroid hormone nuclear receptor 
transcription factors, along with androgen receptors (ARs), where signalling between 
ERα and ERβ is said to be in balance30,39. Transcription factors within this class 
translocate to the nucleus, where they bind directly to hormone response elements 
in the promoters of target genes.30 ERα is no exception to this, where, in the classical 
signalling pathway, ERα homodimers bind directly to oestrogen response elements 
(ERE) in the promoters of target genes.30 ERα homodimer binding is believed to be 
facilitated by the palindromic nature of EREs, which have the consensus sequence 
GGTCAnnnTGACC40,41 (‘nnn’ denotes a 3-nucleotide spacer); although, non-
consensus EREs are still highly responsive to oestrogen41. Circulating oestrogens 
include estrone (E1), estradiol (E2) and estriol (E3), where E2 is the primary 
circulating oestrogen.30 ERα acts as a RNAPII-mediated transcription co-activator as 
it modifies chromatin through recruitment of co-regulatory proteins, stabilises the 
pre-initiation complex and promotes the recruitment of RNAPII.30  
Structurally, ER classes have conserved DNA-binding and ligand-binding domains 
(LBDs) but divergent N-terminal domains (Figure 4B).30 The N-terminal domain and 
the LBD, which are known as activation function(AF)-1 and -2 respectively (Figure 
4B), recruit co-regulatory proteins to DNA-bound ER to promote transcription.30  
ER signalling is implicated in growth, migration, differentiation and apoptosis of cells, 
as well as angiogenesis, and is hence often implicated in cancer, such as that of breast 
tissue.30 In addition to the classical pathway, ER signalling can also occur through 3 
distinct pathways, which are classified as being either genomic or non-genomic, as 
well as either ligand-dependent or ligand-independent.30 Although, the classical 
signalling pathway (genomic and ligand-dependent) remains the best 
characterised.30  
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The first of these pathways is termed the ‘cross-talk’ pathway (genomic and ligand-
dependent). In the absence of EREs, ER homodimers can cross-talk with other 
transcription factors such as Fos/Jun42 or stimulating protein-1 (SP-1)43. In the 
genomic but ligand-independent pathway, growth factor signalling is believed to 
activate kinases which in turn phosphorylate and activate the ER instead of 
oestrogens, which would ordinarily bind and activate ERs in the classical signalling 
pathway.44 This ligand-independent mechanism is believed to be implicated in 
hormone-independent growth of some cancers.30  Finally, in the non-genomic but 
ligand-dependent pathway, which is considered the least understood30, G-protein-
coupled receptors (GPCRs), like GPCR-3045, are activated through oestrogen-bound 
ERs. This results in a signalling cascade via secondary messengers (SMs) and a rapid 
physiological response in the cell.30 It is this response, such as an increased 
intracellular NO concentration, that is thought to enable non-genomic transcriptional 
regulation.30 This is also called the membrane-initiated steroid signalling (MISS) 
pathway and is believed to account for the rapid action of oestrogens observed in 
some cell types.46 A summary of these signalling mechanisms is shown in Figure 4A.  
In the classical pathway, ligand binding induces a conformational change in ERs which 
enables translocation to the nucleus. This conformational change occurs in the AF-2 
domain of ERs, specifically helix 12 (H12).30 ER ligands can either be agonistic or 
antagonistic, depending on what conformational change is brought about in H12.30 
For instance, binding of agonistic ligands causes H12 to adopt an open conformation 
with a shallow hydrophobic binding site for the leucine-rich LxxLL motif of co-
activators.30 Whereas, when antagonists bind, some believe H12 mimics the LxxLL 
motif, hence blocking the co-activator docking site.30 Others believe binding of co-
repressors, such as silencing mediator for retinoid and thyroid hormone receptor 
(SMRT), is prevented by an extended co-repressor box.30 The recruitment of co-
regulatory proteins to AF-2 is important for correct ER signalling. For instance, over-
expression of ‘amplified in breast cancer 1’ (AIB1) – an ER transcriptional co-activator 
– is observed in breast cancer.30  
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Figure 4: Oestrogen receptor mechanisms of signalling and structure 
(A) Oestrogen receptor (ER) signalling is classified into ligand-dependent and independent 
pathways. In the classical pathway, ligands bind to the ER causing homodimerisation and 
subsequent translocation to the nucleus, where ERs bind to oestrogen response elements in 
the promoters of target genes.30 ERs can also signal through ‘cross-talk’ with other 
transcription factors such as Fos/Jun.30 In the non-genomic pathway, either a classical ER, an 
ER isoform or a distinct receptor is activated upon ligand binding causing a rapid physiological 
response via second messengers inside the cell, such as increased NO levels or an influx of 
ions.30 In the ligand-independent pathway, signalling is achieved through growth factor 
signalling, which in turn activates kinases which phosphorylate/activate ERs.44 (B) Schematic 
of the structural organisation of human (h) ERa and ERb, where the structure of ERa has 
been sub-divided into domains A to F. ERa and ERb have a highly conserved DNA-binding 
domain (DBD), with 2 ZFs, a less-well conserved ligand-binding binding domain or LBD (also 
known as activation function (AF-2) and a highly divergent N-terminal AF-1 domain.30 The 
percentage sequence homology between the receptors is shown. Figures taken from 
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Fili et al (2017) demonstrated, through pull-down assays, that ERα binds MVI at the 
nuclear receptor LxxLL binding motif in the CBD, where site-directed mutagenesis of 
this motif prevents binding.7 MVI was shown to have a functional role in the 
regulation of ERα-driven transcription, since knockdown of the motor protein 
reduced expression of ERα target genes – PS-2 and GREB-1 – by 85% and 40% 
respectively.7 Using a luciferase reporter assay, Fili et al (2017) also demonstrated 
that MVI has the potential to regulate expression from ERE promoters, supporting a 
role for MVI in ER-driven gene expression.7  
Nuclear MVI has been shown previously to have a functional role in androgen-
dependent gene expression, where MVI and ARs have been shown to bind through 
co-immunoprecipitation assays in LNCaP cells; MVI is also thought to recruit ARs to 
the promoters of target genes.47 Therefore, the finding that MVI also binds to ERα 
demonstrates a functional role for MVI, in relation to steroid hormone nuclear 
receptor transcription factors, beyond just ARs.7 This is particularly significant given 
the over-expression of MVI in prostate, breast48 and ovarian49 cancer, where 
signalling through hormone receptors is implicated in driving cancer progression.   
8.5 Myosin VI and NDP52 – a putative transcription co-activator  
The name NDP52 comes from initial immunohistochemical studies that showed dot-
like nuclear staining and co-localisation with nuclear domain 10 (ND10) proteins, 
such as promyelocytic leukaemia (PML) and Sp100.50 The term ‘52’ comes from a 
molecular weight (MW) of 52kDa (446 amino acids), which was predicted through 
isolation and sequencing of cDNA.50 NDP52, along with tumour necrosis factor 
receptor-associated factor 6 (TRAF6)-binding protein (T6BP), also known as TAX1BP1, 
were identified as binding partners of MVI using two-hybrid screens in yeast and 
Chinese hamster ovary (CHO) cells, as well as co-immunoprecipitation assays.31 Site-
directed mutagenesis revealed that both NDP52 and T6BP bind to MVI at the RRL 
motif in the C-terminal CBD, where the ZF motifs of both NDP52 and T6BP are 
required for binding.31  
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Initial Kyte and Doolittle51 plots predicted a central hydrophilic region of 
approximately 200 amino acids in NDP52, between amino acids 134-350, with high 
probability of forming an α-helical coiled-coil (supported by the absence of 
prolines).50 Within the coiled coil, between amino acids 324-345, a LZ is predicted.50 
NDP52 is also predicted to have small clusters of hydrophobic amino acids at the N- 
and C-termini, with high probability of forming β-sheets and -turns.50 This is 
consistent with the presence of a skeletal muscle and kidney enriched inositol 
phosphatase (SKIP) carboxyl homology (SKICH) domain and a lin-1, isl-1 and mec-3 
(LIM)-like (LIM-L) domain at the N- and C-termini respectively (Figure 5A).50 NDP52 
is hence predicted to have globular structures at its ends (Figure 5B).50  
Other proteins, such as CALCOCO1 (or CoCoA), SKIP, and T6BP, are also characterised 
by a SKICH domain52, where NDP52 and T6BP are both autophagy receptors53. This 
128-amino acid domain is responsible for translocation of SKIP from the endoplasmic 
reticulum to sub-membranous actin at plasma membrane ruffles upon epidermal 
growth factor (EGF) stimulation (in COS7 cells).54 The same phenomenon is observed 
for proline-rich inositol-polyphosphate 5-phosphatase (PIPP)54 but unexpectedly was 
not observed with T6BP and NDP52 upon EGF stimualtion31. Although, RNAi-
mediated knockdown of both T6BP and NDP52 shows that these proteins are 
required for actin filament organisation because there is reduced membrane ruffling 
at the leading edge and an increase in stable actin stress fibres.31 The SKICH domain 
of NDP52 is hence believed to facilitate plasma membrane localisation.31  
Aforementioned, NDP52 is also characterised by the presence of a C-terminal LIM-L 
domain, as well as a SKICH domain. The LIM domain is a unique double-ZF motif, with 
the consensus sequence C-X2-C-X16-23 -H/C-X2-C/H-X2-C-X2-C-X15-30-C-X1-3-C/H/D 
responsible for coordinating 2 zinc (Zn2+) ions.55 The C-terminus of NDP52 
demonstrates high sequence homology with the consensus sequence of a LIM 
domain, sharing 6 cysteine residues.50 Hence, NDP52 has a C-terminal double-ZF 
motif. LIM domains have been characterised in kinases, adaptors and importantly, 
with regard to NDP52, transcription factors.55  
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Despite the structural information presented above, there are currently no 
crystallography structures available for full-length NDP52. However, the structure of 
the NDP52 ubiquitin-binding ZF has been determined by nuclear magnetic resonance 
(NMR; PDB entry – 2MXP) and the SKICH domain of NDP52 similarly determined by 
X-ray crystallography (PDB entry – 3VVV). These structures have been incorporated 
into the schematic shown in Figure 5. 
 
Figure 5: NDP52 structure 
(A) Schematic of NDP52 structure. NDP52 is characterised by the presence of a skeletal 
muscle and kidney enriched inositol phosphatase (SKIP) carboxyl homology (SKICH) domain, 
a central coiled-coil region containing a leucine zipper (LZ) at the C-terminal and a double 
zinc finger (ZF) lin1, isl-1 and mec-3 (LIM)-like (LIM-L) domain.50 Not drawn to scale. Figure 
adapted from Korioth et al, 1995. (B) Cartoon representation of expected secondary 
structure content of NDP52.  SKICH domain – PDB entry 3VVV; ZFs – PDB entry 2MXP.  
LIM domains are believed to facilitate protein-protein interactions, such as those 
observed between paxillin and binding partners including α- and γ-tubulin.55 When 
NDP52 was initially shown to co-localise with ND10 proteins, the identification of a 
LIM-L domain (between amino acids 395-446) supported the conclusion that NDP52 
could mediate interactions between ND10 proteins such as Sp100 and PML.50 
Subsequently, however, it was found that this observed co-localisation, through use 
of mAb C8A2 to stain for NDP52,  was an artefact of C8A2 cross-reacting with Sp100 
and NDP52 does not associate with nuclear dots (NDs).56 NDP52 instead exhibits 
mainly cytoplasmic and diffuse nuclear staining, suggesting that NDP52 can be 
localised to the nucleus but not to NDs, despite its original name.56 Two-hybrid assays 
also demonstrated that NDP52 forms a homodimer; NDP52 is hence likely to exist as 
a non-ND-associated dimeric or multimeric protein.56 
B
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NDP52 interestingly has no nuclear localisation signal (NLS)50, depsite being 
characterised as a putative transcription factor7. Nuclear localisation can therefore 
be explained by unregulated diffusion through nuclear pores or binding to a 
cytoplasmic protein targeted to the nucleus.50 Interestingly, green fluorescent 
protein (GFP)-tagged NDP52 has not been observed entering the nucleus31, 
suggesting that GFP may impair nuclear import of NDP52. 
NDP52 is well-characterised in biological processes including cell adhesion31 and 
macro-autophagy57. For instance, RNAi-mediated knockdown of NDP52 reduces 
focal adhesion formation.31 For the remainder of this section, the focus will be 
NDP52’s role in autophagy.  
Autophagy, or the self-degradative process in cells, is responsible for clearing cells of 
aggregated proteins, damaged organelles and intracellular pathogens.58 The 3 
distinct types of autophagy – macro-, micro- and chaperone-mediated autophagy – 
all converge at the lysosome, where proteolysis takes place by lysosomal proteases 
such as cathepsins.58 Macro-autophagy contrasts micro-autophagy, where 
cytoplasmic components are endocytosed directly by the lysosome.58 Macro-
autophagy is instead characterised by the formation of the autolysosome by the 
fusion of the double-membraned autophagosome with the lysosome (Figure 6A).58 
By-products of degradation, including amino acids, are recycled during autophagy 
where they are exported back into the cytoplasm by the action of lysosomal 
permeases and transporters, where they can be used for metabolism and protein 
synthesis.58 
NDP52 is a well-characterised autophagic receptor.59,60 NDP52 binds to ubiquitinated 
cargoes, such as pathogens or mitochondria, through its double-ZF motif (LIM-L 
domain) and selectively recruits them to microtubule-associated protein light chain 
3 (LC3)-positive autophagosomal membranes.59 The way that NDP52 achieves this is 
through binding to autophagy-related protein 8 (Atg8) or LC3 family proteins, such 
as LC3C, though its noncanonical LC3-interacting region (CLIR).60 NDP52 is, therefore, 
along with optineurin (OPTN) and T6BP, a cargo-specific autophagy receptor.60 
Interestingly, OPTN, NDP52 and T6BP are all binding partners of MVI.31,60
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Figure 6: NDP52 is well-characterised in macro-autophagy 
(A) Schematic of macro-autophagy. 1) The phagophore (also known as the isolation 
membrane) expands (2) to engulf its target, such as damaged mitochondria, ubiquitinated 
bacteria or protein aggregates. The subsequent autophagosome (3) fuses with the lysosome 
(4) resulting in an autolysosome (5), which promotes cargo degradation via lysosomal 
enzymes (6).58 LC3 is a characteristic marker of autophagosome membranes.60 (B) NDP52 
promotes autophagosome maturation in macro-autophagy. NDP52, a well-characterised 
autophagy receptor, binds to ubiquitinated cargoes, such as intracellular pathogens during 
xenophagy, as well as LC3 family proteins on autophagosomal membranes, hence targeting 
specific cargoes for autophagy.60 NDP52, bound to LC3-positive autophagosomal 
membranes, also binds myosin VI, linked to endosomal membranes via Tom-157,61, to 
promote autophagosome maturation. (C) NDP52 binds different LC3 family members via 
different domains. NDP52 has a noncanonical LC3-ineracting region (CLIR), which binds LC3C, 
as well as a LIR-like domain that binds LC3A, LC3B and or GABARAPL2 to promote 
autophagosome maturation.57 (A) and (B) made with BioRender; (C) taken directly from 
Verlhac et al, 2015. 
In xenophagy (autophagic removal of pathogens), NDP52 has been shown to be 
important for the maturation of bacteria-containing autophagosomes.57 NDP52 
promotes autophagosome maturation by linking MVI, which is bound to endosomal 
membranes via Tom-1, with Atg8 orthologs such as LC3A, LC3B and/or GABARAPL2, 
which are characteristic of autophagosomal membranes (Figure 6B).57,61 Hence, 
NDP52, along with other MVI binding partners, such as OPTN and T6BP, are linkers 
that promote fusion of the endosome and autophagosome.57,61  
NDP52 selectively binds LC3C via its CLIR and displays only weak or no affinity for 
other LC3 family proteins at this region; however, NDP52 binds LC3A, LC3B and/or 
GABARAPL2 (but not LC3C) through a LIR-like motif that lacks hydrophobic residues 
of the conventional LIR motif.57 It was shown that this LIR-like motif is required for 
autophagosome maturation, along with MVI binding, while the CLIR motif is required 
to selectively bind substrates (Figure 6C).57 It is hypothesised that binding to LC3C 
uncovers the LIR-like motif, which is otherwise masked by the coiled-coil domain, 
hence enabling autophagosome maturation through interactions with LC3A, LC3B 
and/or GABARAPL2.57  
Tom-1 binds MVI at the WWF motif53, via a conserved MVI-binding site62, while 
OPTN, NDP52 and T6BP bind MVI at the RRL motif in the CBD53,62. In the case of 
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NDP52, binding to MVI is achieved through the double-ZF (LIM-L) motif62. Alone, 
Tom-1 cannot associate with autophagy receptors (OPTN, NDP52 and T6BP) but can 
in the presence of MVI.62 MVI therefore brings its 2 cargo-binding domains, RRL and 
WWF, in close proximity to enable soluble N-ethylmaleimide sensitive factor 
attachment protein (SNARE)-mediated fusion of the endosomal membrane with the 
autophagosomal membrane, as discussed.24 Interestingly, MVI does not dimerise 
upon binding to Tom-1 which supports an anchoring/tethering role (functioning as a 
non-processive motor) during autophagosome maturation.62 This contributes to the 
growing body of evidence that monomer to dimer transition, regulated by binding 
partners of MVI, is important for the range of functions of this motor protein.62 
Interestingly, NDP52 (CALCOCO2) shares 70% sequence homology with a known 
transcription co-activator – CoCoA (CALCOCO1) – hence suggesting NDP52 may have 
functional roles in transcription.7 This has recently been shown to be the case, where 
NDP52 has been identified as a putative transcription co-activator demonstrating 
roles beyond autophagy and cell adhesion.7 MVI has been shown to exist in an auto-
inhibited conformation, where there is backfolding between the CBD and tail 
domain.7 This was demonstrated in vitro using Förster resonance energy transfer 
(FRET)-based assays, as well as in vivo using fluorescence lifetime imaging.7 In this 
auto-inhibited state, the DNA-binding sites are occluded.7 However, upon unfolding, 
MVI is capable of binding DNA.7 Calcium, actin and ATP are not responsible for this 
unfolding event, and instead unfolding is attributed to the MVI binding partner – 
NDP52.7 
It is suggested that there are 2 NDP52-dependent routes for MVI dimerisation.7 In 
one pathway, NDP52 unfolds MVI first before recruiting a second MVI monomer (I; 
Figure 7A), whereas in the other pathway, 2 MVI monomers are unfolded before 
dimerisation (II; Figure 7A).7 MVI dimerisation involves either a single NDP52 dimer 
(stoichiometry of 2:2) or 2 NDP52 dimers (stoichiometry of 2:4).7 These routes are 
dependent on the concentration of NDP52, which implies that different pathways 
may be employed for different functions and at different times.7  
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Binding of MVI to RNAPII is dependent on DNA binding; hence, through unfolding 
MVI, which promotes DNA binding, NDP52 enhances RNAPII-mediated transcription 
and can be described as a transcription co-activator.7 The functional role of NDP52 
in transcription is further supported by:  
o co-immunoprecipitation of RNAPII with full-length NDP52 from HeLa extracts;  
o partial co-localisation of RNAPII and NDP52, shown by immunofluorescence 
(Figure 7B);  
o strong binding affinity of full-length NDP52 for double-stranded DNA or 
dsDNA (Figure 7C);  
o and the observation that transcription decreases by ~50% in vitro upon 
depletion (sequestering) of NDP52, using HeLaScribe extracts (Figure 7D).7  
Similar to NDP52, depletion of MVI reduced transcription by ~75% (Figure 7D), 
supporting a functional role for MVI in transcription.7  
MVI is believed to bind RNAPII through both its CBD and motor domain; it is believed 
these domains bind DNA and/or binding partners, as well as nuclear actin, 
respectively (Figure 7E).7 Therefore, MVI is thought to form a bipartite association 
with RNAPII, where the unfolded state of MVI could enable the motor to act 
processively during transcription or form a molecular anchor.7 For instance, it is 
hypothesised that nuclear MVI may have functional roles in anchoring RNAPII in so-
called ‘transcription factories’, where it is thought RNAPII is localised in discrete foci 
to enhance transcription rates.63 
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Figure 7: NDP52 activates myosin VI to enhance RNAPII-mediated transcription 
(A) Proposed mechanism of NDP52-facilitated dimerisation of myosin VI. Myosin VI could 
first dimerise before the second myosin VI is unfolded by NDP52. Alternatively, respective 
myosin VI monomers could unfold before NDP52-facilitated dimerisation. (B) NDP52 (green) 
partially co-localises with RNAPII (magenta) in punctate structures. DNA shown in cyan; scale 
bar of 10μm for whole images and 1μm for inserts. (C) NDP52 binds double-stranded DNA 
(dsDNA) with high affinity. NDP52 was titrated against 50nM ds40. Data fitted as described 
in Fili et al, 2017 (average of 3 independent experiments). (D) Depletion of NDP52 and 
myosin VI reduces transcription in HeLaScribe transcription assays. Antibodies against 
myosin VI and NDP52 were used to sequester the proteins respectively. Depletion of myosin 
VI reduces transcription to 25%, while depletion of NDP52 reduces transcription to 50%. 
Error bars represent the standard error of the mean, where ** denotes a p-value of <0.001 
by a 2-tailed t-test from 5 independent experiments. (E) Myosin VI forms a bipartite 
association with RNAPII. Myosin VI is believed to bind a binding partner and/or DNA at its C-
terminal cargo-binding domain, while the N-terminal motor domain is believed to bind 
nuclear actin. Figures taken from Fili et al, 2017.  
8.6 Project aims 
As discussed, NDP52 and ERα are binding partners of MVI, binding at the RRL and 
LxxLL motifs in the CBD respectively, hence supporting a role for MVI in 
transcription.7 The main aim of this work is to take a multi-disciplinary approach to 
biochemically and biophysically characterise these transcription regulators 
associated with MVI, in the hope that this will elucidate further the role of MVI in 
transcription and ultimately cancer.  
As part of this work, purification methods of ERα need to be optimised to achieve a 
reproducible, high-yield, reliable and relatively inexpensive method. Previous 
attempts at purifying full-length hERα have proven difficult in a range of expression 
systems, including bacteria64,65, yeast66 and baculovirus65 cell lines. One of the main 
aims of this project is hence to successfully optimise the purification of full-length 
ERα using the BL21 Escherichia coli (E.coli) strain as the expression vector, owing to 
its short generation times and relative low cost. This will enable further binding 
assays  and other biochemical analysis to better understand the interaction between 
ERα and MVI, particularly in relation to transcriptional regulation.  
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NDP52 is well-characterised in cell adhesion31 and autophagy57 but little is known 
about its role in transcription, where it has only recently been identified as a putative 
transcription co-activator.7 Fili et al (2017) demonstrated that full-length NDP52 can 
bind dsDNA with high affinity (Figure 7C).7 Hence, this work aims to employ 
biochemical methods to characterise the DNA-binding characteristics of different 
structural domains.  
NDP52 is also believed to function as a homodimer in vivo56. This project, therefore, 
aims to use size-exclusion chromatography-multi-angle light scattering (SEC-MALS), 
as well as photobleaching analysis using total internal reflection fluorescence (TIRF) 
microscopy, to probe the structure and oligomeric state of NDP52. This project also 
aims to develop and trial a novel GFP-based assay, with cryogenic super-resolution 
microscopy, to investigate whether NDP52 homodimers adopt a parallel or anti-
parallel state, as well as successfully use small-angle X-ray scattering (SAXS) to gain 
structural insights into full-length NDP52. This is particularly important to help 
elucidate NDP52’s role as a regulator of transcription. For instance, a parallel 
conformation may suggest NDP52 can bind tightly to DNA, potentially clamping down 
on it, whereas an anti-parallel configuration may suggest that NDP52 acts as a linker.  
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9 Materials and Methods  
9.1 Materials and reagents  
Table 1: Source list for materials and reagents 
Material Source Composition 
A0106 
Integrated DNA 




Acrylamide 37.5:1, 30% 
solution Alfa Aesar Chemicals - 
Amicon Ultra centrifugal 
filter Merck-Millipore  
Ammonium persulfate (APS) Fisher Scientific™ UK 10%w/v stock 
Ampicillin (Amp) Melford Laboratories Ltd 100mg/mL stock 
Bovine serum albumin (BSA) 
Sigma-Aldrich UK 
- 
Catalase 17mg/mL stock 





acetic acid  
Dithiothreitol (DTT) Melford Laboratories Ltd 1M stock  
Glucose Fisher Scientific™ UK - 
Glucose oxidase Sigma-Aldrich UK - 




HisTrap™ Fast Flow (FF) 
column - 
Imidazole Acros Organics™ - 
Isopropyl β-D-1-
thiogalactopyranoside (IPTG) Melford Laboratories Ltd 1M stock  
Luria Bertani (LB) broth 
Thermo Fisher Scientific 
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Material Source Composition 
Nu-PAGE Novex® - 
Phenylmethylsulfonyl 
fluoride (PMSF) Melford Laboratories Ltd 100mM stock 
Sodium dodecyl sulphate 
(SDS) Thermo Fisher Scientific 10%w/v stock 
Spin-X centrifuge tube filter Costar® - 
Sucrose Thermo Fisher Scientific - 
Superdex™ 200 Increase 
10/300 GL column 
GE healthcare 
- 
Superose™ 6 Increase 
3.2/300 column - 
Tetramethylethylenediamine 
(TEMED) Thermo Fisher Scientific - 
TetraSpeck™ beads Invitrogen – Thermo Fisher Scientific  
Tris (hyrdoxymethyl 
methylamine) Thermo Fisher Scientific - 
Vivaspin® 20mL 10K device Sartorius - 
 
9.2 Standard expression protocol for recombinant proteins 
9.2.1 Transformation of recombinant DNA  
Using a 1:25 dilution of DNA vector to competent BL21 DE3 (Invitrogen™) E.coli cells, 
recombinant DNA was transformed using heat shock at 42°C for 45s. Both before and 
after heat shock, cells were incubated on ice for 30min and 2min respectively. Post-
heat shock and recovery on ice, cells were incubated for 1hr at 37°C in LB broth (1:5 
dilution) and plated aseptically onto LB agar before overnight incubation (37°C). 
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Table 2: List of expression vectors 
Expression Vector (Residue Numbers) Affinity Tag Antibiotic Resistance 






Human pET151 His-tag NDP52 (1-190) 
Human pET151 His-tag NDP52 (120-end) 
Human pET151 GFP-NDP52 (1-end) 
Human pET151 GFP-NDP52-GFP (1-end) 
Residue numbers are shown in brackets. pET151 refers to the T7 expression system in E.coli.  
9.2.2 Overnight/starter culture 
Transformed single colonies were cultured overnight at 37°C in LB broth 
supplemented with 100μg/mL Amp (Table 2). 
9.2.3 Expression and resuspension 
Starter culture was added (1:100 dilution) to LB broth and incubated at 37°C, on 
rotation at 150rpm, until an OD600 of between 0.5 and 0.7AU was reached. Expression 
was induced upon the addition of 1mM IPTG – a molecular mimic of allolactose – 
which displaces the repressor from the T7 promoter. Following induction, the 
temperature was reduced to 18°C and cells incubated overnight.  
Cells were harvested by centrifugation at 4,000rpm for 20min at 4°C and 
resuspended in resuspension buffer (50mM Tris-HCl pH 7.5, 40mM imidazole, 
200mM NaCl, 1mM DTT, 20% w/v sucrose, 100µM PMSF). Cell pellets were defrosted 
and lysed on ice by sonication at 30s intervals (at 14 Amplitude Microns) for a total 
of 5min 30s (5 repeats), where thawing aids lysis. The supernatant (soluble cell 
lysate) from subsequent centrifugation (18,000rpm for 30min at 4°C) was used for 
purification.  
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9.3 Immobilised metal-ion affinity chromatography and size-exclusion 
chromatography 
The supernatant was purified using a 5mL HisTrap™ FF column (Table 1), which was 
pre-packed with pre-charged Ni Sepharose® hence enabling rapid purification of His-
tagged recombinant proteins. The Ni2+ ions (on Ni Sepharose®) coordinate histidine 
residues, which are out-competed upon increasing concentrations of imidazole 
(Figure 8). The HisTrap™ column was equilibrated in Buffer A (50mM Tris-HCl pH 7.5, 
40mM imidazole, 500mM NaCl, 1mM DTT) before stepwise increases (20, 40, 75 and 
100%) in Buffer B (50mM Tris-HCl pH 7.5, 400mM imidazole, 500mM NaCl, 1mM DTT) 
hence generating an elution profile. A gradient elution was also employed, where 
stated. Although, stepwise elution should be assumed as the default method. Protein 
elution was monitored on the ÄKTATM chromatography system by measuring the 
intrinsic fluorescence of tryptophan residues at 280nm, where imidazole also 
absorbs at 280nm. The purity of fractions yielding a large UV peak were assessed by 
SDS-PAGE and purified further by gel filtration/size-exclusion chromatography if 
necessary. This protocol was modified, where stated, by equilibrating the column in 
Buffer A without any imidazole.  
Gel filtration (size-exclusion chromatography) separates proteins according to 
molecular size (Stokes radius) and was employed to obtain a higher degree of purity 
compared with affinity chromatography alone. Affinity chromatography fractions 
were passed through a HiLoad™ 16/600 Superdex™ 200 (Table 1) column, 
equilibrated with gel filtration buffer (50mM Tris-HCl pH 7.5, 150mM NaCl, 1mM 
DTT). The Superdex™ column is a matrix of dextran and highly cross-linked agarose, 
where, depending on the interaction time with the matrix, proteins elute at different 
time points, with larger molecules eluting first from the column. As with affinity 
chromatography, protein elution was tracked measuring absorbance at 280nm.  
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Figure 8: Principle of Ni Sepharose® purification 
Nickel ions coordinate His-tagged proteins. Upon treatment with Buffer A (low imidazole), 
unwanted/non-specifically bound proteins are eluted, while the His-tagged protein remains 
bound to the column matrix. Upon treatment with Buffer B (high imidazole), imidazole out-
competes histidine for the nickel ion meaning that the protein of interest (His-tagged) is 
eluted.  
9.4 Denaturing SDS-PAGE  
SDS-PAGE gels were cast by hand, consisting always of a 4% stacking gel and either 
an 8 or 12% resolving component. Protein samples were denatured prior to loading 
by heating at 95°C for 10 minutes. Gels were ran in SDS-PAGE running buffer (25mM 
Tris, 1.4% w/v glycine, 1% SDS), stained with Coomassie Brilliant Blue solution (Table 
1) and imaged using Image LabTM software. PageRuler™ Plus Pre-Stained Protein 
Ladder (Table 1) was used throughout (Figure 9). MWs of unknown proteins were 
determined manually (where stated) using calibration curves, where the logMW (in 
kDa) of known protein standards was plotted against relative mobility (Rf). The 
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Figure 9: PageRuler™ Plus Pre-Stained Protein Ladder molecular weight markers 
9.5 Beer-Lambert law  
Absorbance was measured at 280nm using the LVis Plate and the CLARIOstar® High 
Performance Monochromator Multimode Microplate Reader. Protein extinction 
coefficients (ε) in M-1cm-1 were determined using ProtParam (Supplementary Table 
7). The extinction coefficient, absorbance and pathlength (1cm) were used in the 
Beer-Lambert Law to determine protein concentration.  
9.6 DNA-binding assays  
9.6.1 Sample preparation 
Changes in fluorescence intensity were used to assess the affinity of protein-DNA 
interactions. Protein samples (at concentrations stated in text, always in excess of 
DNA) were serial diluted (1:2 dilution) against 100μL of 100nM DNA, either dsDNA or 
single-stranded DNA (ssDNA), where ssDNA acted as a negative control.  
dsDNA samples were annealed by mixing equimolar and equal volumes of 
complementary strands (Table 3), heating at 95°C for 2min and allowing to cool for 
2-3hrs at room temperature (RT), whereas ssDNA samples were not. 3’ fluorescein-
labelled DNA was employed for binding assays with non-fluorescent protein.   
Protein and DNA samples were diluted in binding assay buffer (50mM Tris-HCl pH 
7.5, 100mM NaCl, 3mM MgCl2) to achieve desired concentrations and experiments 
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were performed at RT. Fluorescence intensity readings were taken using the 
following experimental setup: excitation wavelength – 489nm, excitation bandwidth 
– 16nm, emission wavelength – 517-656nm and emission bandwidth – 10nm.  Data 
presented is at 517nm and an average of ≥3 independent experiments. Raw data was 
divided by the dilution factor and normalised before percentage change calculations. 
For all graphs, error bars are plotted as the standard error of the mean.  
Table 3: List of oligonucleotide sequences employed for DNA-binding assays 
Referred 
to in Text Description 
Trade 
Name  Oligonucleotide Sequence 
ds40 Random dsDNA of 40bp 
A0107 TTAGTTGTTCGTAGTGCTCGTCTGGCTCTGGATTACCCGC* 
A0106 GCGGGTAATCCAGAGCCAGACGAGCACTACGAACAACTAA 
ss40 Random ssDNA of 40bp A0107 TTAGTTGTTCGTAGTGCTCGTCTGGCTCTGGATTACCCGC* 
ds15 Random dsDNA of 15bp 
A0108 TTAGTTGTTCTCTGG* 
A0110 CCAGAGAACAACTAA 
ss15 Random ssDNA of 15bp A0108 TTAGTTGTTCTCTGG* 
Oligonucleotide sequences are written in the conventional 5’ to 3’ direction. 
9.6.2 Data fitting 
Average readings were fitted to the quadratic equation (assuming 1 binding site) 
using GraFit67, which accounts for all titration conditions:  [". $%&]= 	 ([$%&] + [",] + [-.]) −	1([$%&] + [",] + [-.])2 − 4	([$%&] ×	[",])2  
Where:  
[P.DNA] = protein-DNA complex 
concentration (M) 
[PT] = total protein concentration (M) 
[DNA] = concentration of DNA (M) 
KD = equilibrium dissociation constant 
(M) 
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9.7 Circular dichroism  
9.7.1 Sample preparation  
Circular dichroism (CD) is defined as the differential absorbance of left-handed and 
right-handed circularly polarised light, where the differential absorbance (ΔA) can be 
employed to deduce information about the secondary structure content of proteins 
and hence assess protein folding. A typical reference spectrum for CD is shown in 
Figure 10.  
 
Figure 10: A typical circular dichroism reference spectrum for protein secondary structure  
Taken directly from Greenfield, 2007.  
ΔA and ellipticity (θ) values, which are the conventional output for CD spectra, can 
be interconverted using the equation:  
Δ& = 732982 
Where:  
θ = ellipticity (mdeg) A = absorbance (AU) 
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Experiments were performed in the far-UV (190-250nm), which provides information 
relating to the peptide bond; whereas, near-UV (250-330nm) provides information 
relating to aromatic side chains. The following parameters were used for full 
spectrum measurements: temperature – 20°C, wavelength range – 190-270nm, data 
pitch – 1nm, scanning mode – continuous, scanning speed – 100nm/min, response – 
0.5sec, bandwidth – 20nm, 1mm pathlength quartz cuvette and an accumulation of 
4 (4 readings taken before being averaged). Whereas, for thermal stability assays, 
the same parameters were employed but in the range of 20-80°C, using a pitch of 
2°C. Melting curves were fitted using the Boltzmann Equation; for proteins 
containing largely α-helices, the equation was fitted at 222nm while for proteins 
containing largely β-sheet, data was fitted at 214-217nm. All measurements were 
performed using Jasco J715 software and data ≥600V was ignored (represents 
detector saturation). Protein concentrations used are stated in text and dilutions 
were achieved with gel filtration buffer unless otherwise stated. 
9.7.2 Analysis 
CD outputs or ellipticity values (θ, measured in mdeg) were converted to mean 
residue ellipticity ([θ], measured in deg.cm2.dm-1) using the equation below. This 
accounts for the number of amino acid residues and enables proteins of different 
MW to be compared: 
[7] = 	 ; <=% − 1? 710AB  
Where:  
[θ] = mean residue ellipticity 
(deg.cm2.dm-1) 
θ = ellipticity (mdeg)  
MW = molecular weight (g/mol)  
N = number of amino acid residues  
c = concentration (g/L) 
l = pathlength (cm)  
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Protein secondary structure estimation was quantified using KD23. K2D2 (older 
version of K2D368) estimates protein secondary structure using a reference set of CD 
spectra from proteins with solved crystallography structures69. K2D3, however, 
employs a larger reference set of PDB entries for which the CD spectra have been 
predicted.68 For input into K2D3, θ values were converted into mean residue circular 
dichroism (ΔεMR) using the following equation. Again, ΔεMR allows CD spectra from 
proteins of different MW to be easily compared: 
∆D<E =	 ∆&AB% 
Where:  
ΔεMR = mean residue circular 
dichroism (M-1cm-1) 
A = absorbance (AU)  
c = concentration (M) 
l = pathlength (cm) 
N = number of amino acid residues  
9.8 Size-exclusion chromatography-multi-angle light scattering  
SEC-MALS couples SEC, which separates proteins according to their molecular size, 
with MALS (Figure 11A); hence, enabling accurate determination of MW and 
investigations into the oligomeric state of proteins. Photons from the incident beam 
are absorbed by the macromolecule and re-emitted in all directions (Figure 11B). 
Using the Rayleigh Equation (Figure 11C), which defines the relationship between 
light scattering and MW, the MW of the macromolecule can be determined by 
measuring the intensity of light scattering. The intensity of the scattered light is 
proportional to the MW of macromolecules, hence scattered light from a dimer is 
twice as intense as that from a monomer.  
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NDP52 protein samples were subjected to SEC-MALS, using a Superdex™ 200 
Increase 10/300 GL column (Table 1). All buffers were de-gassed before use and the 
column washed in Milli-Q™ H2O at 0.1mL/min overnight before use. The SEC column 
was then equilibrated in gel filtration buffer (50mM Tris-HCl pH 7.5, 150mM NaCl, 
1mM DTT) by running at 0.75mL/min for at least 2hrs, which protein samples were 
also diluted in. For each run, equipment was ‘autozeroed’ and protein samples were 
injected at a volume of at least 200µL. Once all runs were completed, the column 
was placed in water and then ethanol, running at 0.1mL/min overnight and 
0.3mL/min for 2-3hrs respectively. Importantly, all protein samples were filtered 
Spin-X centrifuge tube filters (Table 1) before use to prevent aggregates entering and 
blocking the column. Measurements and analysis were performed using OmniSecBio 
software, where calibration was achieved with bovine serum albumin (BSA) 
standards (1mg/mL, 2.5mg/mL and 5mg/mL).
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Figure 11: Setup and analysis using SEC-MALS 
(A) Setup of SEC-MALS equipment. Buffers are de-gassed before being pumped/loaded onto a SEC column where MALS detectors measure the intensity of 
scattered light at different directions. Analysis is then performed using OmniSecBio software. Figure generated in BioRender. (B) Macromolecules emit 
photons from the incident beam in different directions, referred to as light scattering. (C) The Rayleigh Equation defines the relationship between light 
scattering and molecular weight. 
!"#$ = %&' + 2*2+ %,$
BA
C
C = sample concentration (M)
θ = measurement angle (◦)
Rθ = Rayleigh ratio (ratio of scattered light intensity vs. 
incident light intensity) at measurement angle, θ
MW = molecular weight (Da)
A2 = second virial coefficient
Pθ = defines angular dependence
K = constant dependent on sample, solvent and system
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9.9 Total internal reflection fluorescence microscopy 
9.9.1 Etch-cleaning of coverslips 
Glass coverslips were cleaned using stabilised Etch solution at 70°C, composed of a 
5:1:1 ratio of H2O:H2O2:NH4OH. Coverslips were incubated for 2-3hrs at 70°C and 
then washed thrice in Milli-Q™ H2O and once in absolute ethanol before being 
allowed to dry overnight. Before use, coverslips were placed under UV light for 10-
15 minutes.  
9.9.2 Sample preparation  
100µL of sample (at the concentration stated in text), diluted in TIRF microscopy 
buffer (25mM NaCl, 20mM imidazole pH 7.4, 20mM Tris-HCl. pH 7.5, 0.1mg/mL 
glucose oxidase, 0.02mg/mL catalase, 3mg/mL glucose), was placed onto the 
coverslip before covering with an opaque object for 5 minutes (as glucose oxidase is 
light-sensitive). The sample was then removed, and the coverslip completely covered 
with TIRF buffer for imaging.  
TIRF microscopy analysis makes use of photobleaching properties of fluorophores, 
hence the presence of an oxygen scavenger system (Figure 12) is important.  Glucose 
oxidase sequesters oxygen, preventing bleaching, while catalase promotes protein 
activity by preventing hydrogen peroxide (H2O2) accumulation (Figure 12).  
 
Figure 12: Oxygen scavenger system used in TIRF buffer 
dsDNA for TIRF microscopy (Table 4) was annealed in the same way as for DNA-
binding assays but was non-fluorescent as proteins were labelled with enhanced GFP 
(eGFP). Non-fluorescent dsDNA was used at 100nM (diluted in TIRF buffer) and 
incubated with protein samples for 10 minutes (in the dark) before being loaded onto 
coverslips for a further 5 minutes (15-minute total incubation time).  
Glucose + O2 Gluconic Acid + H2O2
H2O2 H2O + ½ O2
Glucose Oxidase
Catalase
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Table 4: List of oligonucleotide sequences employed for TIRF analysis 
Referred to in 









9.9.3 Imaging  
Imaging was performed in TIRF buffer, in the presence of an oxygen scavenger (as 
described). Images were acquired using a ZEISS Elyra P1 system with a Plan 
Apochromat 100x 1.45 numerical aperture (NA) oil immersion lens. Samples were 
illuminated with a 488nm laser and images were acquired at 20hz with an electron-
multiplying charge-coupled device (EMCCD) camera (Andor).  A total of 1000 frames 
were recorded for each time series/cycle.   
9.9.4 Photobleaching analysis 
Individual GFP photobleaching events were tracked over the 1000-frame time series 
using a single-fluorophore detection algorithm (SFDA) and extracted using 
GMimPro70. A frame size of 5x5 and a 10-frame window were employed. The 
threshold for photobleaching events was set at 7 counts/pix based on the change in 
intensity between fluorescent and background states. This was calculated based on 
the number of spots detected within a record; for instance, to limit the number of 
false positives, while still enabling spot detection. Traces were assessed manually to 
identify likely (real) GFP molecules, considering GFP is expected to exist for ~5s in 
vitro. Fluorescence traces were classified as either a single or multiple 
photobleaching event, where a drop of intensity to 0 counts/pix was indicative of a 
discrete photobleaching event. The fluorescence lifetime was also measured 
manually by taking point-to-point measurements. A total of 10 (1000-frame) cycles 
were analysed for each condition. 
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9.10 Cryogenic stochastic optical reconstruction microscopy 
9.10.1 Sample preparation  
Under cryogenic (cryo-) conditions, the native ultrastructure of proteins is preserved 
and fluorophore properties change, namely increased brightness and fluorescence 
lifetime.71 Using a super-hemispherical solid immersion lens (superSIL), made of both 
cubic zirconia and platinum (Figure 13A), super-resolution of 12nm of can be 
achieved when plunge-freezing the lens together with the sample.71  
 
Figure 13: Setup of superSIL microscope 
(A) Side- and top-view of solid immersion lens. (B) Schematic of superSIL microscope. Figure 
taken directly from Wang et al, 2019. 
GFP-NDP52-GFP (positive control) and GFP-NDP52 (test condition) at 0.3mg/mL were 
diluted 1:150 in gel filtration buffer. GFP-LifeAct (negative control) at 0.085mg/mL 
was diluted 1:2 in gel filtration buffer and filtered by centrifugation at 4000g for 
10min (Eppendorf table-top centrifuge) using a 50kDa (cut-off) Amicon Ultra 
centrifugal filter (Table 1). Following this, GFP was diluted using a 1:150,000 dilution 
in gel filtration buffer to obtain single-particle labelling on the superSIL substrate 
(0.042mg/mL starting concentration).  
SuperSIL lenses were glow discharged for 120s at 40mA on a Quorum GlowCube 
machine. 2.5μl of the following was added in the order stated: sample, 100nm 
TetraSpeck™ fluorescent beads (Table 1; 1:100 dilution) and sample (again). Blotting 
was performed manually at every step using Vitrobot-compatible blotting paper. 
SuperSIL lenses were then plunge-frozen, together with the sample, into liquid 
BA
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ethane using a Vitrobot plunge-freezer (Field Electron and Ion (FEI), ThermoFisher 
Scientific) before loading onto a magnetic cassette. Cassettes were then secured to 
a translatable stage inside a Linkam CMS196M cryogenic module for imaging. The 
setup of the microscope is shown in Figure 13B. 
A 50x Mitutoyo objective, coupled to a custom microscope71, was focussed through 
the superSIL on to the sample plane. Samples were then illuminated with a 488nm 
continuous wavelength laser at an approximate power density of 1 kW/cm2 with an 
isotropic top-hat profile. The fluorescence signal was then collected by the same 
objective before being sent through an appropriate dichroic beam splitter. The signal 
was then projected onto a Photometrics Prime 95B scientific complementary metal-
oxide semiconductor (sCMOS) camera though a narrowband Semrock 525-25nm 
fluorescence filter. A time series of 10,000 frames was collected per sample using an 
exposure time of 50ms per frame. The datasets were then saved as TIFF stacks for 
data analysis. 
9.10.2 Analysis  
The single molecule localisation software – ThunderSTORM (an ImageJ plug-in) – was 
chosen to analyse the datasets. The effective pixel size was defined as 46.8nm and 
the sCMOS camera was calibrated to 0.98 photoelectrons per analogue-to-digital-
unit (ADU) count. The resultant single molecule localisations were then saved in a 
comma separated variable file for analysis.  
The Ripley’s K-function is referred to as the ‘gold standard’ for spatial point analysis, 
where the original K-function is given by the equation below72: 
!(#, %) = 1) ∙ + 
Where:  
E = expectation (average) number of 
events within radius, r 
λ = intensity (density) of events  
N = total number of events within the 
study area  
r = radius  
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Cluster-analysis was performed on all frames using an inhomogeneous Ripley’s K-
function.73 The inhomogeneous K-function considers both stationary and non-
stationary points within a set area, to investigate the inhomogeneity of the 
distribution.73 K(r) is calculated by looking at the average number of neighbour points 
within a given threshold distance (r) of each other.74 Clustering is identified by 
comparing this value to that expected for a random distribution; with K(r)= πr2  for a 
homogeneous Poisson distribution and K(r)> πr2 for a clustered distribution.74 
The L- and H-functions are based on K(r), where the L-function is the K-function 
normalised by the circle area so that the expected value is r, i.e. linear74:  
,(#) = -(!(#)// 
Similarly, the H-function is the K-function normalised further using the equation 
below to get an approximate value of 0, independent of r, for complete spatial 
randomness (CSR). A positive value for H(r) is indicative of clustering while a negative 
H(r) is indicative of dispersion74: 
0(#) = ,(#) − # 
9.11 SEC-SAXS  
9.11.1 Sample preparation 
SEC-SAXS, which will henceforth be referred to as SAXS, employs X-ray scattering at 
small angles (typically 0.1-0.5°) to deduce structural information on the nanometre 
scale (in the range of 1-300nm). 5mg/mL NDP52 (diluted in gel filtration buffer) was 
sent to Diamond Light Source (UK) for SAXS, where high intensity X-rays from the 
synchrotron were employed. For high performance liquid chromatography (HPLC), 
coupled to SAXS, a Superose™ 6 Increase 3.2/300 column (Table 1), which resolves 
proteins in the range of 5kDa-5MDa, was employed using a 0.16mL/min flowrate. As 
proteins elute off this sizing column, they directly enter the SAXS beamline enabling 
analysis by X-ray scattering.   
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9.11.2 Analysis 
ScÅtter, developed by Robert Rambo at Diamond Light Source75, was employed for 
analysis of solution X-ray scattering data. SAXS scattering images were initially 
plotted as the intensity of scattering (normalised to the concentration of protein) 
against sample number (signal plot). A threshold was then set and subtracted from 
readings to account for the buffer blank using the ‘trace’ function. A Guinier fitting 
was then employed to assess the quality of the sample (discussed in Results).  
Raw SAXS data was then plotted as an intensity plot (intensity vs. scattering vector, 
q) before plotting the average and median of these results (to enable easy 
identification of outliers in the sample). Intensity plots are plotted in reciprocal 
space, where q is measured in Å-1. Hence, small values of q correspond to large 
distance vectors and hence provide information relating to overall size and shape of 
the protein. However, larger values of q provide information at the atomic level.  
Using an indirect Fourier transform (FT), a P(r) model was generated from the 
intensity plot. The P(r) model was refined by varying values of Dmax (maximum 
particle dimension), where a smooth curved was achieved that approaches the x-axis 
gradually. Values for the radius of gyration (Rg), determined by the Guinier fitting and 
the P(r) function, were compared to determine if the P(r) model is well-fitted  
(compare Rg in real and reciprocal space). The intensity plot was also truncated to 
remove noise at higher q (Å-1) values to improve the P(r) model.  
Once the P(r) model was refined, 23 bead models were generated and then 
averaged. A FT was employed to back-transform onto the original intensity plot, 
hence improving the fit (χ2 values used to assess fitting). From this (improved fit), 
another 23 bead models were generated and averaged to create the final SAXS 
envelope.  
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10 Results 
10.1 Optimising the purification of oestrogen receptor a 
10.1.1 Standard expression protocol  
Following the standard expression protocol (Materials and Methods), ERα was 
successfully expressed without degradation, where expression bands are observed 
(Figure 14A) consistent with the expected MW of ERα at ~67kDa (Supplementary 
Table 7). Although, Figure 14B shows that there is considerable localisation to the 
pellet, which prevented purification by affinity chromatography. ERα, however, was 
shown to be soluble through localisation to the supernatant, as shown by the 
presence of a band in line with the 70kDa marker (Figure 14B). Notably, a ~35kDa 
band was observed to increase in band intensity during expression and was also 
present in both the pellet and supernatant (Figure 14), suggesting potential non-
specific over-expression or degradation/cleavage. 
 
Figure 14: Standard expression of ERα 
(A) Expression results. Lane headings denote timings before and after induction with IPTG. 
Arrows mark positions of proteins of interest and relevant molecular weight markers are 
labelled (as with all subsequent SDS-PAGE gels). (B) Results of affinity chromatography. The 
pellet and supernatant following cell lysis are shown, as well as elution fractions (numbered) 
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10.1.2 Modified expression protocols  
In an attempt to reduce localisation to the pellet, the standard expression protocol 
was modified so that: 1) induction was achieved with only 0.5mM IPTG and 2) 
culturing post-induction was only performed for 3hrs at 37°C. Other than these two 
distinct modifications, the standard expression protocol remained the same. These 
modifications will henceforth be referred to as modified protocol 1 and 2. The 
hypothesis was that these modifications would decrease the rate of protein 
synthesis. Hence, decreasing folding intermediates prone to aggregation and 
preventing localisation to the pellet.  
To ensure that ERα was not eluting in 40mM imidazole buffer (Buffer A), imidazole 
was removed from the affinity chromatography equilibration buffer (Materials and 
Methods). Accordingly, cell resuspensions were achieved in 0M imidazole 
resuspension buffer (Materials and Methods). This method was employed for all ERα 
purifications discussed subsequent in this report.   
Both modified protocols resulted in successful expression of ERα (Figure 15A and B). 
However, there was still a large degree of localisation to the pellet, most notably in 
line with both the 70 and 35kDa markers (Figure 15C and D). This was unexpected 
since the modifications were hypothesised to reduce localisation to the insoluble 
fraction (discussed above). Accordingly, ERα was not purified using modified protocol 
1, as shown by the absence of bands in affinity chromatography elution fractions 
(Figure 15C).  
For modified protocol 2, a faint band (red arrow) at the expected MW (~70kDa; 
Supplementary Table 7) is seen in Figure 15D, suggesting successful purification of 
ERα. This was unexpected considering the degree of localisation to the pellet (Figure 
15D) and the results for modified protocol 1. However, this re-iterates that ERα can 
be solubilised and suggests shorter culturing times may be preferential. Interestingly, 
a band at ~35kDa (blue arrow; Figure 15D) is observed, following affinity 
chromatography, at higher intensity compared to the purified ERα band (red arrow; 
Figure 15D), suggesting degradation/cleavage of ERα. 
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Figure 15: Modified expression conditions for ERα 
Expression (A) and affinity chromatography (B) results for ERα following modified protocol 1 
(discussed in text). (C) and (D), as for (A) and (B), except following modified protocol 2. 
Timings relative to induction are given and affinity chromatography elution fractions are 
labelled. ‘Pellet’ and ‘supernatant’ refer to insoluble and soluble fractions following cell lysis.  
10.1.3 Incubation of cell lysate with estradiol  
To further optimise the expression and purification protocol, and ultimately increase 
purification yields, 10µM E2 was incubated with the cell lysate (following sonication) 
for 20 minutes prior to centrifugation and affinity chromatography. Incubation of E2 
with the lysate was hypothesised to stabilise ERα, hence preventing localisation to 
the pellet due to degradation, something which was observed previously for both 
expression rounds (Section 10.1.1 and 10.1.2). Modifications to the standard 
expression protocol, outlined in Section 10.1.2, otherwise remained the same.  
With the additional incubation of E2 with the lysate, protein bands were observed in 
line with the 70kDa marker (expected for ERα; Supplementary Table 7) following 
affinity chromatography. This was true for both modified expression protocols 
(Figure 16A and B). Although, there is again considerable localisation to the insoluble 
cell fraction, in line with the 70 and 35kDa markers (Figure 16A and B). This was 
unexpected since incubation of E2 with the lysate was hypothesised to stabilise ERα 
to prevent localisation to the pellet. However, solubility of ERα was confirmed, for 
both modified expression protocols, by the presence of 70kDa bands in the 
supernatant (Figure 16A, B and C), suggesting E2 promotes solubilisation of ERα.  
Following modified protocol 1, a faint protein band (red box; Figure 16A) is observed. 
However, due to the intensity of the band, protein concentration was not 
determined as it was apparent that further optimisation of the expression protocol 
was required. This was expected considering the degree of localisation to the pellet 
(Figure 16A), although incubation with E2 was hypothesised to decrease this.  
Comparatively, when following modified protocol 2, protein bands are observed in 
line with both the 70 and 35kDa markers following affinity chromatography (Figure 
16B).  
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Gel leakage for Figure 16B was questionable; hence, relevant pooled affinity 
chromatography fractions were re-analysed by SDS-PAGE (Figure 16C). However, 
potential gel leakage was again observed (Figure 16C), especially in line with the 70 
and 35kDa markers. Upon measuring absorbance, an Abs280 corresponding to 
0.6mg/mL was recorded, hence confirming the presence of protein in pooled affinity 
chromatography fractions. Interestingly, when re-examining the concentration of 
purified ERα (Materials and Methods), approximately a week following purification, 
a negative Abs280 was recorded indicative of precipitation. This was unsurprising 
considering consistent localisation of ERα to the insoluble cell fraction. 
Due to likely precipitation (discussed above), modified protocol 2 was repeated. 
However, degradation was observed from 2hrs post-induction (Figure 16D) during 
the expression, which was not observed previously (Figure 15C). Accordingly, the 
soluble fraction (supernatant; Figure 16E) is largely devoid of ERα. In an attempt to 
mitigate degradation, the protocol was repeated but the post-induction culturing 
time was reduced to 2hrs (again, the lysate was incubated with E2). Expectedly, there 
was no degradation during expression (data not shown). However, following affinity 
chromatography, ERα was seen localised to the pellet (Figure 16F) consistent with 
previous purifications (Figure 16B). Unexpectedly, affinity chromatography failed to 
yield purified protein (Figure 16F). This was despite the same expression conditions 
(Figure 16B and C), except reducing the post-induction culturing time to mitigate 
degradation during expression, yielding purified protein.
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Figure 16: Expression and purification results when incubating cell lysate with estradiol 
(A) Affinity chromatography results following modified expression protocol 1 (and incubating 
the cell lysate with 10µM estradiol for 20 minutes, as discussed in text). The elution fraction 
-  A2 - in addition to the supernatant and pellet, are shown. (B) Affinity chromatography 
results for modified expression protocol 2 (again, cell lysate incubated with estradiol). 
Elution fractions are numbered. (C), as for (B), except pooled elution fractions are shown. 
(D) Re-expression of ERα, following modified protocol 2. (E) Corresponding pellet and 
supernatant following centrifugation. (F) Affinity chromatography results upon reducing the 
post-induction culturing time of modified protocol 2 to 2hrs.   
10.1.4 Culturing in the presence of estradiol  
Since a reproducible purification method had not been achieved, 500nM E2 was 
added to the culture medium (LB broth; Materials and Methods) during the 
expression of ERα. This was in addition to incubating the lysate with 10µM E2 (20 
minutes) after sonication. It was hypothesised, like with incubation of the lysate, that 
the presence of E2 during culturing would stabilise the ERα hence preventing 
degradation and improving purification results. The sonication time was also 
increased to a total time of 15 minutes and 30s, employing 30s intervals with 1-
minute breaks, to encourage DNA and membrane fragmentation with the hypothesis 
that this would also improve purification yields. All other parameters, including 
resuspension and column equilibration, in buffer without any imidazole, were kept 
the same.  
For both modified expression protocols (Section 10.1.2), culturing in the presence of 
E2, degradation was observed from 2hrs post-induction (Figure 17A and B). On the 
SDS-PAGE gels, this was observed as a band intensity decrease despite the same 
loading volumes (Figure 17A and B). This was unexpected for modified protocol 1, 
since during the equivalent expression, without E2 in the culture medium, 
degradation was not observed (Figure 15A). However, degradation from 2hrs post-
induction during modified protocol 2 had previously been observed, in the absence 
of E2 (Figure 16D), and this result was therefore unsurprising.   
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Figure 17: Expression results when culturing in the presence of estradiol  
(A) Expression results when following modified protocol 1, culturing in the presence of 
500nM E2 (discussed in text). (B), as for (A), except following modified protocol 2.  
Both modified expression protocols were hence refined to prevent degradation 
during expression. Cells were only cultured for: 1) 2hrs at 18°C post-induction, 
inducing with 0.5mM IPTG and 2) 2hrs at 37°C post-induction, inducing with 1mM 
IPTG. Increased sonication time and incubating the cell lysate with 10µM E2 
remained the same. These protocols will be referred to modified protocol 3 and 4 
respectively. Expression following these protocols expectedly prevented degradation 
during culturing (data not shown).  
Nickel-ion affinity chromatography was performed on the supernatant from both 
modified protocol 4 and 3, in this order. However, affinity chromatography did not 
yield purified protein due to an air block in ÄKTATM Pure chromatography system, 
which meant no high (400mM) imidazole buffer was being injected into the 
chromatography system (data not shown). After purging, this issue was resolved, and 
the resulting elution profile/chromatogram is shown in Figure 18C. The peaks and 
troughs of the chromatogram have been aligned with the SDS-PAGE gel (Figure 18A 
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Figure 18: Affinity chromatography and gel filtration results following purging of the 
ÄKTATM pump 
Affinity chromatography results for the purification of ERα after purging pump B, 
corresponding to modified expression protocols 4 (A) and 3 (B), as discussed in text. (C) 
Chromatogram corresponding to affinity chromatography, showing the elution profile for 
purification. Corresponding regions of the chromatogram and SDS-PAGE analysis are shown 
using colour-coordinated boxes. (D) Gel filtration results corresponding to pooled affinity 
chromatography fractions A1-12.  
When monitoring the Abs280 using the ÄKTATM Pure chromatography system, 
absorbance values were high in fractions A1-2 before decreasing in fractions A3-5 
(Figure 18C). Similarly, in fractions A6-7, absorbance values are high before a gradual 
decline in Abs280 in elution fractions A8-12 (Figure 18C). This was supported by SDS-
PAGE band intensities following the same pattern (Figure 18A and B).  
In the SDS-PAGE gel, the positions of protein bands in line with the 70kDa marker (as 
well as the 35kDa marker) have been marked by arrows (Figure 18A and B). Protein 
bands in line with the 70kDa marker likely correspond to ERα at ~67kDa 
(Supplementary Table 7). Elution fractions A1-2 likely correspond to elution of ERα 
from the first affinity chromatography run (corresponding to modified protocol 4), as 
shown in Figure 18A. Elution fractions A3-5, however, likely correspond to 
degradation between affinity chromatography runs as there is a decrease in Abs280 
(Figure 18C) and band intensity (Figure 18A). Elution fractions A6-12 likely represent 
elution of ERα from modified protocol 3, where the highest protein concentration is 
in fractions A6-7, supported by both SDS-PAGE band intensities (Figure 18A and B) 
and Abs280 readings (Figure 18C). 
Gel filtration (Materials and Methods) on pooled affinity fractions A1-12 
demonstrates that purified ERα elutes in gel filtration fraction C9 (red arrow; Figure 
18D), where the corresponding protein band is  estimated at ~87kDa using the SDS-
PAGE calibration curve. Following concentration of appropriate gel filtration 
fractions, a final protein concentration was achieved of 15.8mg/mL. However, 
precipitation was observed in vitro, and, despite centrifugation, large variability in 
absorbance values was observed hence questioning the reliability of the protein 
concentration estimate. Expectedly, when measuring the protein concentration 
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approximately a week after purification (after centrifugation), a negative absorbance 
was recorded, demonstrating precipitation. This was despite a clear band on the SDS-
PAGE gel (Figure 18D). This was unsurprising since degradation had previously been 
observed following successful purification (Section 1.1.1). 
Successful purification of ERα, when culturing in the presence of 500nM E2 (Figure 
18D), supported the hypothesis that E2 stabilises native ERα during folding. 
Although, there is still localisation to the pellet in line with the 70 and 35kDa markers 
(Figure 18A) suggesting a degree of degradation and/or precipitation even with E2 
present. Both successful expressions (modified protocols 3 and 4) involved culturing 
for 2hrs post-induction, re-iterating that shorter culturing times are likely to be 
preferential (Figure 15D), as well as the presence of E2 in the culture medium. 
However, differences in temperature do not appear to significantly influence 
purification results (Figure 18A and B).  
10.1.5 Regular additions of estradiol to the culture medium  
During modified protocol 1 (culturing at 18°C overnight post-induction and inducing 
with 0.5mM IPTG) with E2 present in the culture medium, there is degradation of 
ERα 2hrs after induction (Figure 17A) – something that is not observed with E2 
absent from the culture medium (Figure 15A). This is surprising since E2 is 
hypothesised to stabilise native ERα during folding and hence it is unexpected to see 
that the presence of E2 in the culture medium promotes degradation. However, it 
can be hypothesised that this result is due to the degradation of E2 itself during 
overnight culturing. To investigate this, 500nM E2 was added continually to the 
culture medium during expression (modified protocol 1). E2 was added at the 
following time points: 0hr, 3hr, 3hr post-induction and 4.5hr post-induction. 
Figure 19A demonstrates that regular additions of E2 prevents degradation of ERα 
during culturing, as expected. Subsequently, there is purification of ERα by affinity 
chromatography, where the lysate was incubated with E2 prior to purification (as 
discussed in Section 10.1.4). This was observed on 2 distinct occasions, but protein 
concentrations are low demonstrated by weak band intensities (Figure 19B and C). 
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This re-iterates that the presence of E2 in the culture medium improves purification 
results and that shorter culturing times are preferential.  
 
Figure 19: Expression and affinity chromatography results following regular additions of 
500nM estradiol to the culture medium  
(A) Expression results following modified protocol 1, where the cell lysate was incubated 
with 10µM E2 and 500nM E2 added to the culture medium at 0hr, 3hr, 3hr post-induction 
and 4.5hr post-induction. (B) and (C). Affinity chromatography results, from 2 distinct 
expressions, following this protocol. Purified ERα is marked with a red arrow.  
Despite the range of expression and purification conditions trialled, it was not 
possible to gain a high yield of stable purified protein for biochemical and biophysical 
characterisation. Efforts were therefore turned to another transcription regulator 
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10.2 Biochemical and biophysical characterisation of nuclear dot 
protein 52 
10.2.1 Expression and purification of NDP52 structural domains  
To biochemically and biophysically characterise structural domains of NDP52, 
residues 1-190 and 120-end were expressed. These domains largely represent the N-
terminal SKICH domain (1-190) and the remainder of the protein (120-end), with 
overlap (Figure 20). These protein domains will be referred to as NDP52 1-190 and 
120-end throughout the remainder of the document.  
 
Figure 20: Schematic of NDP52 domains – NDP52 1-190 (A) and NDP52 120-end (B) – not 
drawn to scale 
10.2.1.1 Modified standard expression protocol  
NDP52 1-190 and NDP52 120-end were expressed following the standard expression 
protocol (Materials and Methods), modified so that cells were incubated at 27°C 
overnight. This decision was based on previous NDP52 expressions performed in the 
Toseland laboratory. Expression was successful in both cases, where protein bands 
are observed between the 35 and 55kDa markers (blue arrow; Figure 21A) and in line 
with the 25kDa marker (red arrow; Figure 21B), consistent with the predicted MWs 
of NDP52 120-end and 1-190 at ~40kDa and ~23kDa respectively (Supplementary 
Table 7). Degradation was observed for both NDP52 120-end and 1-190 (Figure 21A 
and B) as a decrease in band intensity from 3hrs post-induction, which was more 
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Correspondingly, no protein was obtained by affinity chromatography for NDP52 
120-end, which was confirmed by SDS-PAGE analysis and negative Abs280 readings 
(data not shown). 
However, following affinity chromatography and gel filtration (Figure 21C and D), a 
high protein concentration was obtained for NDP52 1-190 suggesting degradation 
during expression was insignificant. On repeat purifications, similar results to Figure 
21C and D were observed (data not shown). Notably, gel filtration did not result in 
completely pure fractions for NDP52 1-190 due to the presence of protein bands 
other than those in line with the 25kDa marker, such as a ~70kDa band marked with 
a green arrow (Figure 21D). This may suggest a potential protein complex or 
oligomerisation.  
 
Figure 21: Expression of NDP52 120-end and 1-190 following the standard expression 
protocol modified to culture at 27°C overnight  
Expression results for NDP52 120-end (A) and NDP52 1-190 (B), where a representative 
expression SDS-PAGE gel for NDP52 1-190 is shown. Affinity chromatography (C) and gel 






















































































Hannah Reed 69 
10.2.1.2 Modified expression protocol for NDP52 120-end  
In an attempt to mitigate degradation, in order to purify NDP52 120-end, the 
standard expression protocol, as described in Materials and Methods, was modified 
so cells were only cultured for 3hrs post-induction at both 18°C and 37°C. NDP52 120-
end was expectedly successfully expressed with both modified protocols (Figure 22A 
and E). Following cell lysis, NDP52 120-end localises to both the soluble and insoluble 
cell fractions (for both modified protocols) demonstrating solubilisation of NDP52 
120-end and some potential degradation (Figure 22B and F). Again, for both modified 
protocols, affinity chromatography (Figure 22B, C and F) and gel filtration (Figure 22D 
and G), yielded purified NDP52 120-end. Although, complete purification was not 
obtained for neither expression protocol (Figure 22D and G) as multiple protein 
bands are present on SDS-PAGE gels, much like NDP52 1-190, such as those in line 
with the 130 and 100kDa markers (again marked with green arrows). Again, 
potentially reflecting oligomerisation or binding partners of NDP52 120-end.  
When repeating NDP52 120-end expressions, cells were cultured for 3hrs at 18°C 
post-induction. Correspondingly, all NDP52 120-end results presented from this 
point onwards refer to these expression conditions. This decision was based on the 
observation that higher protein concentrations were obtained at this temperature, 
suggesting it is optimal. 
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Figure 22: Modified expression protocol results for NDP52 120-end 
Expression (A), affinity chromatography (B and C) and gel filtration (D) results corresponding to the expression protocol where cells were cultured for 3hrs at 
18°C post-induction but otherwise following the standard expression protocol. Representative expression (E), affinity chromatography (F) and gel filtration 
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10.2.2 Secondary structure content of NDP52 1-190 and 120-end  
CD was performed on NDP52 1-190 and 120-end to assess protein folding after 
purification, to determine if further characterisation was possible. NDP52 1-190 
(0.1mg/mL diluted in 50mM Tris-HCl pH 7.5, 50mM NaCl) was shown to be 0.7% α-
helical and 44% β-strand by analysis with K2D368 (Figure 23B). These estimates are 
consistent with the expected secondary structure of the SKICH domain (Figure 23A), 
suggesting purified NDP52 1-190 is suitable for biochemical and biophysical analysis 
(folded correctly).  
Fitting the Boltzmann Equation at 215nm (Materials and Methods), gave a midpoint 
temperature (Tm) of 57±0.2°C (Figure 23D). This is clear on Figure 23C, where there 
is an obvious shift in thermal stability between 50 and 60°C. The midpoint 
temperature is the temperature where 50% of protein molecules are said to be in an 
unfolded state. This demonstrates that NDP52 1-190 is stable at RT, which 
fluorescence-based binding assays are performed at.  
 
Figure 23: Circular dichroism analysis for NDP52 1-190  
(A) Cartoon schematic of secondary structure content of full-length NDP52, with residues 1-
190 shown in a red box (not drawn to scale). (B) Full spectrum measurements for 0.1mg/mL 
NDP52 1-190 (diluted in 50mM Tris-HCl pH 7.5, 50mM NaCl) at 20°C. (C) Circular dichroism 
spectra for 1mg/mL NPD52 1-190 (in gel filtration buffer) at varying temperatures (20-80°C) 
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NDP52 120-end (0.1mg/mL diluted in 50mM Tris-HCl pH 7.5, 50mM NaCl), however, 
was shown to be 61% α-helical and 4% β-strand according to K2D368 (Figure 24B). 
Again, this is consistent with the expected secondary structure content of NDP52 
120-end, where the coiled-coil region is α-helical, whilst the ZFs contribute anti-
parallel β-sheet (Figure 24A). The Boltzmann Equation was fitted at 222nm giving a 
Tm of 50±0.2°C (Figure 24C and D). Again, this demonstrates NDP52 120-end is folded 
correctly and stable enough for further characterisation.  
 
Figure 24: Circular dichroism analysis for NDP52 120-end  
(A) Red box highlighting predicted secondary structure content of NDP52 120-end (not 
drawn to scale). 0.1mg/mL NDP52 120-end (diluted in 50mM Tris-HCl pH 7.5, 50mM NaCl) 
was subjected to circular dichroism analysis at 20°C (B). 1mg/mL NDP52 120-end, diluted in 
gel filtration buffer, was also subjected to circular dichroism analysis in the range of 20-80°C 
(C). (D) The Boltzmann Equation was fitted to circular dichroism data at 222nm to estimate 
the melting temperature for NDP52 120-end.  
10.2.3 NDP52 structural domain DNA-binding affinities  
Having successfully purified both NDP52 1-190 and 120-end, fluorescence intensity 
binding assays, as described in the Materials and Methods, were employed to 
investigate binding affinities for different structural domains of NDP52. Previous 
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high affinity but, here, efforts were made to further refine DNA-binding 
characteristics of the protein domains. Binding curves for positive and negative 
controls are shown in Supplementary Figure 41 and Figure 42.  
Figure 25A and B show that NDP52 1-190 and 120-end bind to ds40 with high affinity, 
where both have a dissociation constant (KD) of <100nM when fitted to the quadratic 
equation. KD estimates in this order of magnitude are expected given NDP52’s role in 
transcriptional regulation, where tight binding to DNA would be expected. Like with 
ds40, NDP52 120-end binds to ds15 with high affinity with a KD of 1.1±0.3µM (Figure 
25D). Although GraFit estimates the KD for 1-190 binding to be 188±157nM, the error 
in the prediction is large owing to poor fitting of the binding curve meaning that an 
accurate KD cannot be determined (Figure 25C).  
 
Figure 25: Binding assay results for NDP52 1-190 and 120-end  
5µM NDP52 1-190 (A) and NDP52 120-end (B) were titrated against 100nM fluorescein-
labelled ds40. 10µM NDP52 1-190 (C) and NDP52 120-end (D) were titrated against 100nM 
fluorescein-labelled ds15. Data presented is an average of at least 3 separate experiments. 
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10.2.4 Investigating NDP52 oligomeric states using SEC-MALS  
To investigate oligomerisation of NDP52 and make predictions about its tertiary 
structure, SEC-MALS was performed on NDP52 1-190 and 120-end domains. Figure 
26A and B respectively show the SEC-MALS elution profiles for NDP52 1-190 and 
NDP52 120-end at 1, 2.5 and 5mg/mL. For both NDP52 1-190 and 120-end, the 
average MW of peak 2 was taken at 2.5mg/mL and 5mg/mL, whereas the average 
MW for peak 1 was taken using all protein concentrations. Anisotropic readings were 
excluded from the data analysis (Supplementary Figure 43).  
For NDP52 1-190, peak 1 has an average MW of 19kDa, while peak 2 an average MW 
of 42kDa (Figure 26A). Therefore, peak 2 for NDP52 1-190 is approximately double 
that of peak 1. Similarly, for NDP52 120-end, peak 1 has an average MW of 33kDa 
whereas peak 2 has an average MW of 74kDa (Figure 26B); again, peak 2 has 
approximately double the MW of peak 1. Notably, peak 2 for NDP52 120-end does 
not follow a characteristic bell-shape curve, with a shoulder marked by a grey box in 
Figure 26B. This shoulder is at the limit of the resolution of the column, suggesting 
aggregation. This shoulder was hence excluded from calculations determining the 
MW of peak 2.  
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Figure 26: SEC-MALS elution profiles for NDP52 1-190 and 120-end  
(A) Elution profile for NDP52 1-190 at 1, 2.5 and 5mg/mL coloured blue, red and black 
respectively. (B) Same for (A) except for NDP52 120-end.  The shoulder of peak 2 for NDP52 
120-end is marked by a grey box. Peak limits used for analysis are defined in magenta for 
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10.2.5 eGFP-labelled NDP52 expression and purification  
10.2.5.1 Modified standard expression protocol 
Results from SEC-MALS elucidated that NDP52 is likely dimeric in vitro (see 
Discussion). Efforts were therefore made to further investigate the arrangement of 
the NDP52 dimer, namely whether it adopts a parallel or anti-parallel form, to further 
elucidate the role of the protein in transcriptional regulation. For instance, as an anti-
parallel dimer, NDP52 may act as a linker between DNA and another protein. 
Whereas a parallel conformation may confer tight binding to DNA.  
For these investigations, a novel GFP-based reporter assay was developed, using 
cryogenic super-resolution microscopy. The concept behind this design was that 
distances between GFP fluorophores could be directly measured. Both N-terminally 
eGFP-tagged NDP52 (GFP-NDP52; Supplementary Table 7) and doubly-tagged NDP52 
(GFP-NDP52-GFP; Supplementary Table 7) were therefore required to act as the test 
sample and positive control respectively (see Section 10.2.7). GFP-NDP52 was also 
required for TIRF microscopy to support investigations into the oligomeric state of 
NDP52.  
eGFP-tagged variants of NDP52 were expressed in E.coli following the standard 
expression protocol, modified so cells were cultured at 27°C post-induction, like 
initial expression conditions for NDP52 1-190 and 120-end. Affinity chromatography 
was performed using stepwise increases of imidazole (Materials and Methods). The 
affinity chromatography column was equilibrated in Buffer A, without any imidazole, 
to avoid eGFP-tagged NDP52 variants eluting in low imidazole concentrations (as 
observed for ERα previously). This decision was taken in the interest of time for 
collaboration work. All purifications for eGFP-tagged NDP52 variants, presented from 
here onwards, therefore employ 0M imidazole Buffer A and 0M imidazole 
resuspension buffer (Materials and Methods).  
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GFP-NDP52 was successfully expressed (Figure 27A) and localised to the supernatant 
(Figure 27B), demonstrating solubility. Bands consistent with the expected MW of 
GFP-NDP52 at ~80kDa (Supplementary Table 7) are marked with arrows (Figure 27A 
and B). Expectedly, GFP-NDP52 was purified by affinity chromatography (Figure 27C). 
However, the presence of multiple protein bands at lower MW suggests degradation 
(Figure 27C). GFP-NDP52 was, therefore, expectedly lost during gel filtration (gel not 
shown) likely due to degradation.  
The successful expression of GFP-NDP52-GFP (~100kDa; Supplementary Table 7), 
however, is questioned by the absence of a clear expression band around the 100kDa 
marker (Figure 27D). However, following affinity chromatography, protein bands 
consistent with the expected MW (red arrow; Figure 27E) are observed in both the 
pellet and supernatant (demonstrating solubility), as well as in elution fractions, 
hence confirming successful expression. However, band intensities (Figure 27E) for 
affinity chromatography elution fractions were weak and accordingly, upon 
determining protein concentration, negative Abs280 readings were recorded. 
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Figure 27: Expression and affinity chromatography results for GFP-NDP52 and GFP-NDP52-GFP culturing at 27°C post-induction 
Expression of GFP-NDP52 (A) following a modified version of the standard expression protocol (culturing at 27°C post-induction) and analysis of the 
supernatant and pellet (B) following cell lysis. (C) Affinity chromatography results for GFP-NDP52, namely equilibrating the Ni Sepharose® column with 0M 
imidazole Buffer A and using stepwise elutions to elute protein fractions. Expression (D) and affinity chromatography results (E) for GFP-NDP52-GFP using the 
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10.2.5.2 Standard expression protocol 
In an attempt to improve purification yields for both GFP-NDP52 and GFP-NDP52-
GFP, the post-induction culturing temperature was reduced from 27°C to 18°C 
(standard expression protocol; Materials and Methods). The hypothesis being this 
would slow expression rate and hence improve purification results. Both GFP-NDP52 
and GFP-NDP52-GFP were expectedly successfully expressed following this 
expression protocol (data not shown) and purified by affinity chromatography (using 
0M imidazole equilibration buffer). Although, unexpectedly, the degree of 
purification by affinity chromatography (Figure 28A and C) was less compared to 
culturing at 27°C post-induction observed previously (Figure 27C and E). 
GFP-NDP52 and GFP-NDP52-GFP were then subjected to gel filtration, and unlike 
culturing at 27°C post-induction, yielded purified protein (Figure 28B and D). Notably, 
a higher degree of purification was observed for GFP-NDP52-GFP (elution fraction 
C5; Figure 28D) compared to GFP-NDP52 (elution fraction C2; Figure 28B). Again, 
complete purification was not observed for GFP-NDP52 nor GFP-NDP52-GFP (Figure 
28B and D). 
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Figure 28: Affinity chromatography and gel filtration results for GFP-NDP52 and GFP-NDP52-GFP following the standard expression protocol  
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10.2.5.3 Gradient elution affinity chromatography 
To achieve greater resolution and yield pure fractions (not achieved prior), affinity 
chromatography was performed using a gradient elution (from 0-100% Buffer B) 
compared to stepwise elutions used previously (Materials and Methods). Similarly, 
gel filtration was performed at a lower flowrate of 0.2mL/min compared with 
1mL/min used previously. The protocol for expressions, culturing at 18°C post-
induction (standard expression protocol), as well as equilibrating the affinity 
chromatography column in 0M imidazole Buffer A, remained the same. Obtaining 
pure fractions was important for further characterisation using cryogenic super-
resolution microscopy and TIRF. Results are shown in Figure 29. 
 
Figure 29: Affinity chromatography (gradient elution) and gel filtration (0.2mL/min 
flowrate) purification results for GFP-NDP52 and GFP-NDP52-GFP  
Affinity chromatography and gel filtration results for GFP-NDP52 (A and B) and GFP-NDP52-
GFP (C and D) respectively. Elution fractions C3 and C6, referred to in text, are marked with 
a red box. Other affinity chromatography and gel filtration elution fractions are labelled, as 
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Following the modified protocols for affinity chromatography and gel filtration, pure 
fractions C3 and C6 were obtained for GFP-NDP52 (Figure 29B) and GFP-NDP52-GFP 
(Figure 29D) respectively. This was expected since the modifications were designed 
to improve resolution of fractions. Unfortunately, due to the low protein 
concentration, accurate secondary structure content predictions from CD analysis 
could not be made for GFP-NDP52 nor GFP-NDP52-GFP.   
10.2.6 TIRF microscopy  
To further investigate if NDP52 forms a dimer in vitro, 5nM GFP-NDP52 was used for 
TIRF microscopy (Materials and Methods). Figure 30A shows an even distribution of 
GFP-NDP52 at 5nM. Photobleaching events were monitored using photobleaching 
analysis described in Materials and Method. It is hypothesised that a single 
photobleaching event likely represents a monomeric GFP-NDP52 (Figure 30B), while 
double photobleaching events likely represent dimeric NDP52 (Figure 30C). Example 
single and multiple photobleaching events are shown (Figure 30D and E). 
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Figure 30: TIRF microscopy analysis used to assess oligomeric state of NDP52 
(A) 5nM GFP-NDP52 plated onto Etch-cleaned coverslips and imaged using a TIRF microscope. Yellow arrows highlight positions of single GFP-NDP52 
molecules. Schematic of GFP-NDP52 in monomeric (B) and dimeric (C) form on the coverslip. Results from photobleaching analysis showing representative 
single (D) and double photobleaching events (E). Arrows approximately denote where end-to-end time measurements were taken, as well as the drop in 
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Figure 31A shows that upon incubation with 100nM DNA (non-fluorescent ds40; 
Table 4) more single photobleaching events are observed, with the total number of 
fluorescent events (both single and double photobleaching events) more than 
doubling from 104 to 211 events. However, the percentage of dimers does not 
change considerably both in the presence and absence of DNA at 1% and 0.5% 
respectively, where only 1 dimer was observed in both datasets (Figure 31A). Figure 
31B also demonstrates that both in the presence and absence of DNA, there is a right 
(positive) skew, showing that more GFP-NDP52 molecules exhibit a short lifetime. 
However, in the presence of DNA, the number of GFP-NDP52 molecules exhibiting a 
longer lifetime increases (Figure 31B). In percentages, this equates to 3% of single 
photobleaching events with a lifetime >5s (expected for GFP) in the absence of DNA 
but 7% in the presence of DNA (more than double). There is also an increase in the 
mean lifetime of fluorescent events (single photobleaching events) from 1.4±0.1s to 
2±0.2s in the presence of DNA (error denotes the standard error of the mean). The 
mode lifetime also increases from 0.7s to 1s, as does the maximum lifetime from 6s 
to 20s. 
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Figure 31: Results of photobleaching analysis with TIRF microscopy  
(A) Bar chart showing how the total count of single and double photobleaching events 
(corresponding to GFP-NDP52 monomers and dimers) changes in the presence and absence 
of DNA (100nM non-fluorescent ds40). (B) Bar chart showing the fluorescence lifetime of 
single photobleaching events, again in the presence and absence of DNA.   
10.2.7 Preliminary results for a novel GFP-based reporter assay using cryogenic 
super-resolution microscopy  
As discussed, to investigate if NDP52 adopts a parallel or anti-parallel dimeric 
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resolution) was employed. This technique will be referred to as cryogenic stochastic 
optical reconstruction microscopy (cryo-STORM), which makes use of photoblinking 
properties of fluorophores. It was hypothesised that in the parallel conformation, the 
distance between eGFP tags would be approximately 5nm, while in the anti-parallel 
conformation approximately 30-40nm (Figure 32). Therefore, clusters a distance of 
~40nm apart would be expected for anti-parallel GFP-NDP52 homodimers. These 
estimates were based on previous studies with dynamic light scattering (DLS) in the 
Toseland laboratory. To investigate if NDP52 forms a parallel or anti-parallel dimer in 
vitro, pure gel filtration fractions (Section 10.2.5.3) were used for GFP-NDP52 and 
GFP-NDP52-GFP.  
 
Figure 32: Schematic of N-terminally eGFP-tagged NDP52 in parallel and anti-parallel 
dimeric states 
3 datasets were obtained for GFP-NDP52-GFP (positive control) and GFP-LifeAct 
(negative control), while only 1 dataset was obtained for GFP-NDP52 (test data). 
Importantly, this is preliminary work hence why few datasets were obtained. Figure 
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Figure 33: Raw cryo-STORM data for GFP-NDP52 (test sample)  
(A) Raw cryo-STORM data for GFP-NDP52, taken at 1, 500 and 1000 frames. The first pane 
shows the full dynamic range while the second pane shows the bottom 10% of the dynamic 
range. (B) A maximum intensity projection of 1000 frames of cryo-STORM data showing the 
full dynamic range of the dataset with the TetraSpeck™ fiducial. The red inset extracted in 
(C) has been re-scaled to show the bottom 10% of the dynamic range, showing NDP52 single 
molecules. The valid single molecule detections from ThunderSTORM are overlaid in red on 
extracted inset (D). (E) Enlargement of (D), where single GFP-NDP52 molecules are circled in 
yellow, multiple (clusters) of GFP-NDP52 circled in white and TetraSpeck™ beads highlighted 
with cyan arrows.  
Figure 33E shows that there is a mixed population of single GFP-NDP52 molecules 
and GFP-NDP52 clusters. However, under non-cryogenic conditions, at the same 
concentration, only single GFP-NDP52 molecules are observed (Figure 30A) 
suggesting that GFP-NDP52 aggregates under cryogenic conditions. GFP-tagged 
NDP52 molecules are also currently in 3D orientation, where immobilisation 
uniformly to the surface would improve distance measurements (Discussion). 
Nevertheless, some conclusions can be made regarding similarities in clustering 
behaviour. Figure 34 shows a Kinhom(H’) plot comparing the H(r) values (Materials 
and Methods) for different conditions tested. The black curve (pos_ctrl-neg_ctrl; 
Figure 34) shows that there is a difference in clustering behaviour comparing GFP-
NDP52-GFP (positive control) and GFP alone (negative control). The blue curve 
(test_cond-neg_ctrl; Figure 34) also shows that there is a difference in clustering 
behaviour comparing GFP-NDP52 (test condition) and GFP-LifeAct (negative control). 
However, interestingly, when comparing GFP-NDP52 (test condition) to GFP-NDP52-
GFP (positive control), the H’(r) value is approximately zero (test_cond-pos_ctrl; red 
curve; Figure 34), suggesting that GFP-NDP52 and GFP-NDP52-GFP cluster in the 
same way.
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Figure 34: Kinhom(H’) plot for cryogenic super-resolution microscopy conditions  
Positive, negative and test conditions are discussed in text. Conditions being compared are 
shown in the figure legend. Data analysis and graph by Michael Hirsch. 
10.2.8 SAXS analysis on NDP52 
Currently, there are no X-ray crystallography structures for full-length NDP52. 
Therefore, SAXS was employed for structural investigations. Although, super-
resolution microscopy was initially employed to investigate the dimeric 
conformation of NDP52, experimental and data analysis limitations (Discussion), 
meant that SAXS served as a good alternative to also probe the dimeric orientation 
of NDP52.  
Full-length NDP52 was successfully expressed following the standard expression 
protocol and purified using nickel-ion affinity chromatography and gel filtration 
(Materials and Methods), as shown in Figure 35. Elution fractions C3-C12 were 
pooled and concentrated to a final concentration of 5mg/mL for SAXS.  
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Figure 35: Gel filtration of full-length NDP52, expressing following the standard expression 
protocol 
Figure 36 shows the signal plot overlay with Rg estimates from the Guinier equation 
for peak 1 and 2 of full-length NDP52 SAXS data. Using the Guinier equation, values 
for Rg and intensity at 0° scattering angle (I(0)) can be directly estimated (from SAXS 
images above the buffer blank threshold). This can provide information relating to 
the quality of the sample (Materials and Methods). Rg ‘describes the mass distribution 
of a macromolecule around its centre of gravity’75 and can provide important 
information relating to the shape of the macromolecule. From the Guinier fitting, a 
straight line for Rg (for the sample peak) is indicative of a homogeneous sample and 
hence enables assessment of the quality of the data to be made.  
Figure 36B shows that, for peak 1, the Rg values are extremely varied, suggesting 
aggregation and heterogeneity. However, for peak 2, the Rg values are largely 
constant enabling fitting of a straight line (red dashed line; Figure 36C), suggesting 
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Figure 36: Guinier fitting for full-length NDP52 used to estimate I(0) and Rg values 
(A) SEC-SAXS signal plot for full-length NDP52 (orange) overlay with Rg estimates from 
Guinier fitting (blue). In the signal plot, each point represents the integrated area of the 
ration of the sample SAXS curve to the estimated background. (B) and (C) represent zoomed-
in versions of plot (A) for peak 1 and 2, where limits are defined as shown in (A). The red 
dashed line in (C) shows an approximate fit for Rg values.  
Figure 37 shows the intensity plots for peak 1 and 2 corresponding to raw and 
averaged SAXS data. Noticeably, for peak 1, both curves are noisier, especially at 
higher q (scattering vector, measured in Å-1) values, compared to peak 2. This would 
be expected for a less homogenous sample, consistent with the Guinier fitting.  
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Figure 37: Intensity plots for peak 1 and 2 of NDP52 sample  
(A) Raw SAXS data from the signal plot (peak 1), accounted for buffer, plotted in reciprocal 
space as intensity values vs. q (scattering vector). (B) Intensity plot of averaged SAX frames 
for peak 1. Averaged (black) and median (cyan) buffer frames are subtracted from the 
averaged sample frames. (C) and (D), as for (A) and (B), but for peak 2.  
Figure 38 shows the intensity plot (Figure 38B) and P(r) function (Figure 38C) used to 
generate a SAXS envelope for NDP52 (Figure 38D). The intensity plot, as described in 
Materials and Methods, is plotted in reciprocal space (Å-1) and is hence converted to 
real space (Å) by means of an indirect FT to create a P(r) model. The shape of the P(r) 
model is indicative of the shape of the protein; for instance, a bell-shaped curve is 
indicative of a globular structure. The shape of the P(r) model for full-length NDP52 
reveals an elongated structure (Figure 38C), which is supported by the SAXS 
envelope, where full-length NDP52 is seen to adopt an asymmetric linear/elongated 
shape (Figure 38D). This is expected considering SEC-MALS data (Figure 26). From 
SAXS, NDP52 is also predicted to have an end-to-end length of 50nm (Figure 38D), 
consistent with expectation from previous DLS experiments with NDP52, where the 
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Figure 38: SAXS envelope for full-length NDP52  
(A) Intensity plot of averaged SAX frames for peak 2 (as for Figure 37D). (B) Truncated intensity plot for P(r) function analysis. Fitting is shown by the red 
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11 Discussion  
11.1 Culturing in the presence of estradiol significantly improves 
purification results for ERα 
Many proteins of interest are present in low abundance in vivo, insufficient for 
biochemical studies, hence prompting many researchers to turn to recombinant 
methods and expression in a foreign host.77 This is particularly true for mammalian 
cells, where it is well-characterised that steroid hormones are expressed at low levels 
(although over-expression can occur in cancer).64 E.coli as an expression system has 
long been employed for such work as it demonstrates many advantages such as short 
generation times, efficient nutrient conversion and vast practical and theoretical 
knowledge regarding the organism’s biochemistry, genetics and physiology.77  
In this study, E.coli was employed for expression of recombinant hERα for reasons 
outlined above. Previously, the expression and purification of the LBD of ERα has 
been optimised in E.coli BL21 DE3 cells using a pET expression vector78, as well as in 
E.coli TOPP-3 cells77. Similarly, full-length ERα has been purified from E.coli strains 
AR58 and AR6864, as well as yeast66 (Saccharomyces cerevisiae), as a ubiquitin-fused 
protein. While Eiler et al (2001)78 employ the same expression system as that used in 
this study (E.coli BL21 DE3 cells), only the LBD is purified; similarly, when full-length 
ERα is purified, it is so only as a ubiquitin-fusion protein. Here, however, for the first 
time in the literature, full-length ERα (without ubiquitin-fusion) is purified using the 
E.coli BL21 strain. 
Different expression and purification conditions were trialled to optimise the 
purification yield for ERα. A summary of these steps is shown in Figure 39. Culturing 
in the presence of 500nM E2 and increased sonication time markedly increased 
purification results compared to other methods, including incubating the lysate with 
10µM E2 prior to sonication (only) as seen in Figure 16. This was true culturing both 
at 37°C and 18°C for 2hrs post-induction (Figure 18). This result is consistent with 
other studies that have demonstrated the presence of this ligand during culturing 
(both at 500nM and 10µM) improves purification results.77,78 It is believed that E2 
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increases the stability of native ERα during folding77,78, which, in addition to increased 
solubility facilitated by longer sonication times, improves the purification result. For 
instance, by increasing the stability of native ERα, there is a reduced population of 
partially denatured or unfolded ERα prone to aggregation.77  
 
 
Figure 39: Summary of optimal expression and purification conditions used for ERα  
Optimal conditions used are shaded in grey. Figure inspired by Eiler et al, 2001.  
Interestingly, degradation of ERα is observed in the presence of E2 in the culture 
medium (Figure 17A) but not in its absence (Figure 15A) when following modified 
protocol 1 (culturing at 18°C overnight post-induction and inducing with 0.5mM 
IPTG). It was hypothesised that this was due to the degradation of E2 itself during 
culturing. Results presented in this study show that regular additions of E2 during 
culturing prevents such degradation of ERα (Figure 19), supporting the hypothesis 
that E2 is important for stabilising ERα during folding. However, ERα degrades both 
in the presence (Figure 17B) and absence (Figure 16D) of E2 in the culture medium 
when following modified protocol 2 (culturing at 37°C for 3hrs post-induction and 
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short for degradation of E2 during culturing and there must be other contributing 
factors towards the degradation of ERα. It is hypothesised, therefore, that even in 
the presence of E2 during culturing, ERα is highly unstable and/or may be being 
degraded due to partial folding (due to the expression of a human gene in a bacterial 
expression system). This is strengthened by the observation that even when culturing 
in the presence of E2, there is consistently localisation to the insoluble cell fraction 
(Figure 18). Other factors that likely contribute towards difficult purification of full-
length ERα are discussed in the following section.  
11.2 Full-length ERα purification: limitations and future direction  
Insolubility, aggregation, instability and degradation were major problems faced 
during optimisation and prevented further work on full-length ERα due to time. 
Examples of these problems are given in Table 5, as well as potential resolutions 
which should be strongly considered for future optimisations. Although, the optimal 
methodology presented (Figure 39) provides a strong foundation for further work. In 
the future, upon the obtainment of higher purification yields, the affinity of the 
interaction between MVI and ERα should be investigated using fluorescence-based 
binding assays, to build upon initial results presented by Fili et al (2017).7 A better 
understanding of this interaction is particularly important if it is to be exploited in 
cancer therapeutics in the future, where MVI is over-expressed in breast and ovarian 
cancers and activation of ER target genes is associated with increased tumorigenic 
potential.7  
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Table 5: Problems encountered during the optimisation of full-length ERα in BL21 E.coli 
Problem Example(s) Resolution 
Degradation/Instability 
Low protein concentrations are achieved even when 
culturing in the presence of E2 (Figure 19), which is 
hypothesised to stabilise ERα 
Presence of E2 in lysis and purification buffers, in 
addition to culture medium, which has been previously 
shown to promote the production of soluble ERα-
LBD78 ERα is shown to degrade during expression both in 
the absence (Figure 16D) and presence of E2 (Figure 
17B) 
Band at ~35kDa observed on all expression and 
affinity chromatography gels, sometimes more 
intense than the 70kDa band for ERα (e.g. Figure 
15D). The 35kDa band may represent non-specific 
over-expression or degradation/cleavage of ERα, 
where degradation is more likely since the 35kDa 
band (half of 70kDa expected for ERα) likely 
represents a monomer of the ERα homodimer.  
Addition of protease inhibitors before, during and 
after sonication, which has previously been shown to 
be optimal for the purification of ERα-LBD77  
Shorter culturing times post-induction have been 
shown to be optimal (Figure 15 and Figure 18) 
Aggregation 
Use of 2% ethanol, in addition to E2 during culturing, 
where E2 is believed to reduce protein aggregation by 
reducing hydrophobic interactions77  
On 2 distinct occasions, ERα was shown to precipitate 
(by measuring negative Abs280 values) following 
purification 
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Problem Example(s) Resolution 
Aggregation 
E.coli cannot perform post-translational 
modifications, potentially making ERα prone to 
aggregation due to incorrect or partial folding 
Purify in insect or mammalian cell lines to ensure that 
necessary post-translational modifications are 
performed 
Insolubility 
Solubility of ERα has been demonstrated by 
localisation to the supernatant but the majority of the 
ERα population consistently localises to the insoluble 
fraction 
Use of 2% ethanol, in addition to E2 during culturing, 
where ethanol is believed to acts as a solubilising 
agent for E277   
Use of detergents such as Sarkosyl or Triton X 
Increased sonication times have been shown to 
promote purification (Figure 18) and reduce 
localisation to the insoluble fraction (Figure 18A vs. 
Figure 15D) 
Ubiquitin-fusion to improve solubilisation, where full-
length ubiquitin-fused ERα has been successfully 
purified using E.coli64 and yeast66. Ubiquitin fusion is 
believed to improve the solubilisation of fused 
proteins due to its hydrophilic outer surface.64 
Longer sonication times/harsher sonication 
Inaccessibility of His-tag 
ERα is expressed well and can be solubilised (Figure 
18A), suggesting that the N-terminal His-tag is 
inaccessible hence limiting the purification of ERα  
Trial different affinity tag to reduce steric hinderance 
which potentially limits binding to the affinity 
chromatography column  
Expression with no affinity tag and purification using a 
Heparin column65 or estradiol-Sepharose® column66 
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11.3 Residues 120-end of NDP52 likely confer binding to dsDNA in vivo 
Previously, full-length NDP52 has been shown to bind to dsDNA (ds40) with high 
affinity (KD < 100nM) in the Toseland laboratory.7 A strong binding interaction has a 
small equilibrium dissociation constant (KD) and a large association constant (KA). In 
this study, the DNA-binding characteristics of structural domains of NDP52 were 
investigated – namely, NDP52 1-190 and NDP52 120-end. NDP52 1-190 largely 
represented the SKICH domain, while NDP52 120-end largely represented the coiled-
coil domain, inclusive of a LZ and double-ZF motif.  
NDP52 1-190 and NDP52 120-end are both shown to bind ds40 with high affinity, 
with KD estimates <100nM (Figure 25A and B). Estimates cannot be made with 
greater precision since the DNA (ligand) concentration was 100nM. Notably, 
however, data points for NDP52 120-end lie closer to the binding curve, suggesting 
there is tighter binding achieved in this structural domain compared to NDP52 1-190. 
For NDP52 1-190, there is a poor fit to the binding curve (Figure 25A) hence it is likely 
that the binding observed in vitro is an artefact of electrostatic interactions that 
would usually facilitate lipid-binding by the SKICH domain54 and binding to dsDNA is 
non-specific. Therefore, it is highly likely that residues 120-end confer binding to 
dsDNA in vivo, which is expected due to the presence of the well-characterised DNA-
binding motifs – LZs and ZFs.  
For ds15, a similar observation is made, where NDP52 1-190 and 120-end bind DNA 
tightly with KD estimates in the nano and micro molar range. Considering KD 
estimates, NDP52 1-190 binds ds15 tighter compared with NDP52 120-end. 
However, like with ds40, the poor fit (Figure 25C) for NDP52 1-190 likely contributes 
to inaccurate KD estimation (large error in the estimation). Figure 25C shows that full-
saturation is not reached for NDP52 1-190 (but could not be fitted due to limitations 
with GraFit software) as a plateau is not observed. Although, this is again likely to be 
an artefact of electrostatic interactions which facilitate lipid-binding in vivo. Similarly, 
for NDP52 120-end, a plateau is not achieved (KD 1.1±0.3µM). The datapoints for 
NDP52 120-end (Figure 25D) lie close to the binding curve and the error for the KD 
estimate is significantly lower compared to NDP52 1-190, demonstrating that this 
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interaction is likely specific (unlike NDP52 1-190). This re-iterates that NDP52 120-
end is likely to confer DNA-binding in vivo.  
For both NDP52 1-190 and 120-end, tighter binding is observed with ds40 compared 
to ds15 (Figure 25) suggesting NDP52 preferentially binds longer oligonucleotide 
sequences. This agrees with the numerous C-terminal DNA-binding domains of 
NDP52, where ds15 may not be able to facilitate all DNA-binding interactions hence 
resulting in lower binding affinities. The binding observed with NDP52 1-190, for both 
ds40 and ds15, is unlikely to be an artefact of NDP52 not being folded correctly. This 
is since NDP52 1-190 was purified multiple times and was predicted to have the same 
secondary structure content by CD analysis (data not shown) and displayed the same 
DNA-binding characteristics in vitro regardless of the purification round.   
All results were compared to positive and negative controls, where NDP52 1-190 and 
120-end were shown not to bind to ss40 (Supplementary Figure 41A and B) and ss15 
(Supplementary Figure 42A and B) in vitro. Positive controls were chosen to be 
NDP52 295-end and ZF1 based on previous work conducted in the Toseland 
laboratory that demonstrated these constructs bind dsDNA reproducibly with high 
affinity. In this study, both 295-end and ZF1 were shown to bind ds40 
(Supplementary Figure 41C and D) and ds15 (Figure 42C and D), confirming DNA was 
annealed correctly. However, it was observed that the binding curves did not plateau 
and saturation was not reached for neither ds40 (Supplementary Figure 41C and D) 
nor ds15 (Figure 42C and D), where fitting and KD estimates are again limited by 
GraFit software.  
Unlike NDP52 295-end (Supplementary Figure 41C and Figure 42C), binding curves 
did saturate for NDP52 120-end (Figure 25). Both constructs encompass the LZ 
domain, as well as the double-ZF motif at the C-terminus; however, NDP52 120-end 
has an additional 175 residues of the coiled-coil domain compared to NDP52 1-190. 
This suggests that the additional residues in NDP52 120-end provide stability and 
favour DNA binding.  
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In the future, DNA-binding affinities of structural domains of NDP52 should be 
evaluated in the presence of MVI, as well as the lipid-binding affinity of the SKICH 
domain in vitro to help further elucidate if NDP52 1-190 binding to dsDNA is an 
artefact of electrostatic interactions. Similarly, binding assays with NDP52 and MVI 
should form the basis of future work given the identification of NDP52 as a putative 
transcription co-activator and MVI over-expression in some cancers.7 Having now 
refined the DNA-binding characteristics of NDP52 structural domains, mutagenesis 
to residues in DNA-binding motifs in NDP52 120-end, should also be assessed using 
binding assays to map key residues important for DNA-binding and hence NDP52 
function as a transcription co-activator. Going forward, it will also be important to 
elucidate the genes that NDP52 transcriptionally regulates with MVI, particularly in 
relation to cancer.  
11.4 NDP52 likely functions as a homodimer in vivo  
The SEC-MALS profile for NDP52 1-190 (Figure 26A) shows that these residues exhibit 
concentration-dependent oligomerisation, where the average MW of peak 2 is 2.2 
times greater than the average MW of peak 1 at 2.5mg/mL and 5mg/mL suggesting 
that a dimer forms at these concentrations. Peak 1 therefore likely represents the 
monomeric state of NDP52 1-190, while peak 2 likely represents the dimeric state 
(Figure 26A). Similarly, NDP52 120-end exhibits concentration-dependent 
oligomerisation, where again peak 2 is 2.2 times greater than the average MW of 
peak 1 (Figure 26B) showing that a dimer forms at 2.5mg/mL and 5mg/mL. This 
supports that NDP52 functions as a homodimer in vivo.50  
SEC-MALS is a method for accurate MW predictions, however, for both NDP52 1-190 
and 120-end the MW estimates show a degree of error compared to the expected 
MWs. For instance, NDP52 1-190 is predicted to be ~23kDa (Supplementary  Table 
7) while SEC-MALS predicts the monomeric state to be 19kDa (Section 10.2.4), 
meaning there is a ~4kDa difference. Similarly, for NDP52 120-end, SEC-MALS 
predicts a MW of 33kDa (Section 10.2.4) for the monomer, while NDP52 120-end is 
expected to be ~39kDa (Supplementary Table 7), meaning there is a difference of 
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~6kDa. Errors with BSA calibration are likely to account for these differences, where 
BSA was not predicted at the correct MW of 66,700Da.  
SDS-PAGE analysis (data not shown) confirmed that these issues with BSA calibration 
were not due to degradation of BSA. Instead, reducing the flowrate of buffer to 
0.5mL/min compared to 0.75mL/min improved BSA calibrations by improving the 
resolution. Unfortunately, SEC-MALS was not repeated due to time limitations and 
low protein concentrations obtained, meaning that all 1mg/mL, 2.5mg/mL and 
5mg/mL concentrations could not be achieved. When repeating SEC-MALS in the 
future, a reduced flowrate should be employed to improve BSA calibrations and a 
Superose™ 6 increase 3.2/300 column, which has a 5kDa-5MDa range, should be 
used to improve the resolution between SEC-MALS peaks. For instance, currently the 
shoulder of the dimer peak (peak 2) for NDP52 120-end is observed at the limit of 
the column volume (Figure 26B).  
Dimerisation of NDP52, as shown by SEC-MALS (Figure 26), is further supported by 
photobleaching analysis with TIRF microscopy, where likely dimeric (double) 
photobleaching events are observed. The observation of dimers at this low 
concentration (5nM) supports the hypothesis that NDP52 is dimeric in vivo.50 
Although, as discussed in Section 10.2.6, dimers only account for 1% (at most) of the 
observed GFP-NDP52 population. Unfortunately, higher concentrations of GFP-
NDP52 could not be employed for TIRF microscopy due to over-crowding of the 
coverslip slide. In the future, immobilisation of GFP-NDP52 onto coverslips may 
improve the percentage of dimers observed at low concentrations.  
The evidence presented here, which supports a homodimeric conformation for 
NDP52, is particularly important in relation to MVI. For instance, NDP52 has been 
shown to unfold/relieve the auto-inhibited state of MVI with a stoichiometry of 
either 2:2 or 2:4.7 Therefore, NDP52 must be dimeric to unfold MVI, which is 
important for transcriptional regulation.7   
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11.5 NDP52 is largely linear with an N-terminal globular domain 
For SEC-MALS, the bed volume for the Superdex™ 200 Increase 10/300 GL column is 
24mL (according to manufacturer specifications), while the void volume is 8-9mL 
(approximately a third of the column volume). NDP52 1-190 elutes between ~12-
17mL (Figure 26A; within the range of the bed and void volumes), suggesting a 
globular state, consistent with the crystal structure for the SKICH domain (PDB entry 
– 3VVV).50 NDP52 120-end, however, elutes between ~9-12mL (Figure 26B) which is 
comparatively earlier compared to NDP52 1-190. This suggests that NDP52 120-end 
adopts a linear conformation, eluting earlier due to its Stokes radius. This observation 
is also consistent with the prediction of a α-helical coiled-coil domain between 
residues 134-350 of NDP52.50 These results from SEC-MALS are also concurrent with 
SAXS, where the both the P(r) function and SAXS envelope (Figure 38) suggest NDP52 
is elongated/linear.  
11.6 The coiled-coil domain of NDP52 likely confers dimerisation and 
provides stability 
Originally, the constructs for investigation were NDP52 1-120, 1-190 and 120-end. 
This design aimed to probe the SKICH domain in isolation (NDP52 1-120), where the 
SKICH domain is from residues 1-128, as well as the remainder of NDP52 (NDP52 120-
end). NDP52 1-190 was therefore designed to represent the overlap between the 2 
constructs. However, NDP52 1-120 could not be purified alone (work conducted by 
colleagues in the Toseland laboratory; data not shown) whereas 1-190 could. This 
suggests that the presence of the coiled-coil region between amino acids 134-190 
(where the entire coiled-coil is between 134-350) increases stability, hence enabling 
purification in E.coli. Similarly, NDP52 120-end contains part of the SKICH domain 
(residues 120-128) to aid protein folding.  
Figure 26 demonstrates that the dimerisation efficiency for NDP52 120-end is greater 
than that for NDP52 1-190, since peak 2 for NDP52 120-end has a greater refractive 
index compared to NDP52 1-190, especially at 1mg/mL. Although, NDP52 1-190 is 
also still shown to dimerise at 2.5mg/mL and 5mg/mL (Figure 26). Since NDP52 1-190 
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is characterised by the presence of the N-terminal of the coiled-coil domain (residues 
134-190) of NDP52, it is likely that the coiled-coil domain facilitates dimerisation, 
concurrent with present belief50. 
11.7 The presence of dsDNA likely promotes the formation of higher 
oligomeric states of NDP52  
Upon the addition of 100nM dsDNA (non-fluorescent ds40), the lifetimes of single 
photobleaching events for GFP-NDP52 markedly increase (Figure 31B). For instance, 
the percentage of events with a lifetime >5s more than doubles, the mean and mode 
lifetimes increase, and events are observed up to 20s in the presence of DNA. This 
suggests that the presence of 100nM non-fluorescent ds40 promotes higher 
oligomeric states of NDP52, although this is not observed as a percentage increase 
in the number of dimers, only as an increase in fluorescence lifetime. For instance, 
the longer lifetime suggests there may be more GFP-NDP52 molecules per spot when 
DNA is present, which is consistent with the presence of a dimer.  
Also, the observation of more monomeric photobleaching events (Figure 31A) in the 
presence of DNA suggests NDP52 is recruited to DNA, consistent with the function of 
NDP52 as a putative transcription co-activator.7 In the future, SEC-MALS elution 
profiles could be employed to investigate if there is a shift in oligomeric states of 
NDP52 in the presence of dsDNA, where you would expect a peak with a higher 
refractive index if more dimers were present. Similarly, in the future (as discussed) 
GFP-NDP52 should be immobilised on the glass surface, potentially through use of 
biotin-conjugated antibodies, to improve the number of fluorophores detected in the 
TIRF setup, which may show a percentage increase in the dimer population.    
11.8 GFP-NDP52-GFP and GFP-NDP52 show the same clustering 
behaviour  
As discussed, NDP52 has been shown to be dimeric through both TIRF and SEC-MALS 
analysis. A GFP-based reporter assay was hence developed to further investigate the 
dimeric state of NDP52, namely whether it adopts either a parallel or anti-parallel 
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state, which is important for structure-function insights into NDP52. For instance, an 
anti-parallel configuration may suggest a linker role for NDP52, with binding sides at 
different ends of the molecule, while a parallel configuration may suggest tight 
binding at one end. The hypothesis was to employ superSIL microscopy, which 
achieves 12nm precision, to measure distances between GFP fluorophores, where 
the use of cryogenic conditions would preserve the native structure of NDP52 and 
increase fluorescence lifetime and brightness of GFP.71  
If employing a FRET-based assay, there would be high FRET between the donor and 
acceptor pair if NDP52 were in a parallel conformation, while in the anti-parallel 
conformation, there would be no FRET as the distance between fluorophores would 
be too great. However, a lack of FRET signal may also imply that that there are no 
dimers and would be indistinguishable from anti-parallel NDP52 homodimers. Also, 
since NDP52 is known to dimerise in the nano molar range, from previous 
experiments in the Toseland laboratory using microscale thermophoresis (where the 
dimerisation KD is between 200-500nM), there would be a low concentration of 
mixed FRET populations. For instance, there would be a low concentration of dimers 
tagged with both GFP and red fluorescent protein (RFP), making FRET changes 
difficult to measure. Therefore, development of a novel GFP-based methodology, 
utilising cryogenic super-resolution microscopy (as discussed), was preferred over a 
FRET-based assay. This was despite the limitations discussed below, which are mainly 
due to recent development, and hence limited user knowledge, of the superSIL 
microscope.  
A key error, which was overlooked when developing the GFP-based methodology 
was the localisation error of the microscope. For this analysis, a localisation error of 
~10nm was achieved for GFP. However, the localisation error is still greater than the 
predicted distance between GFP fluorophores in the parallel conformation (~5nm). 
It was therefore hypothesised that if the distance between GFP fluorophores in the 
test condition (GFP-NDP52) was similar to the positive control (GFP-NDP52-GFP), this 
would infer an anti-parallel NDP52 homodimer. 
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Table 6 outlines further experimental issues relating to superSIL microscopy, as well 
as resolutions which have either been already employed or could be in the future.  
Table 6: Experimental issues with cryogenic super-resolution microscopy 
Issue  Resolution 
Drift of the stage Use of TetraSpeck™ beads (employed)  
Aggregation of GFP-LifeAct 
(negative control) 
Dilution and filtering by centrifugation 
(employed) 
3D orientation of NDP52 through 
blot/freezing process 
Use of surface chemistry, such as biotin-
conjugated antibodies 
Uncontrollable protein 
concentrations due to manual 
blotting 
No current resolution as the entire superSIL 
is plunge-frozen and no alternative plunge-
freezing protocol has been developed 
Aggregation of 5nM GFP-NDP52 
under cryogenic conditions, not 
apparent with TIRF microscopy 
(Figure 30A) 
No current resolution 
Another major issue was data analysis. Currently, cluster-analysis can be performed 
but direct distances between GFP fluorophores cannot be measured. Therefore, 
while you can make comparisons regarding the clustering behaviour, conclusions 
relating to the dimeric conformation of NDP52 cannot be drawn, especially 
considering the clustering behaviour of NDP52 appears to change under cryogenic 
conditions. Neither can conclusions be made about the clustering structure of 
samples. Nevertheless, results show that the clustering behaviour in the positive and 
test condition is the same. Since the positive control is tagged at both the N- and C-
termini with GFP, while the test condition is only tagged at the N-termini, from the 
clustering behaviour, it can be suggested that NDP52 adopts an anti-parallel dimeric 
state at 5nM. However, as discussed, currently only conclusions regarding the 
clustering behaviour can be made.  
There are also issues determining the statistical significance of the results. For 
instance, there is no confidence level associated with K(r) itself. Also, variance in the 
results cannot be estimated because the number of datasets is limited, where only 1 
dataset was acquired for the test condition due to time, meaning that an error 
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calculation would not be possible. To overcome this, the frame ranges could be 
broken down, but the data is time-dependent meaning this is not feasible.  
It is important to stress here that the data presented in this study is preliminary and 
clearly more work needs to be done to optimise this technique. Therefore, in the 
future, if this technique is to be employed to investigate the dimeric conformation of 
NDP52, the issues, discussed above, would need to be addressed. This is particularly 
important given that there are major limitations with alternative methods, such as 
FRET-based assays. However, this methodology does show promise and is something 
that should be continually developed going forward. Although, this is not to say that 
other methods, such as X-ray crystallography, should not also be pursued.  
11.9 SAXS suggests NDP52 adopts a parallel homodimeric state in vitro  
As discussed, cryogenic super-resolution microscopy was limited by providing only 
comparisons regarding the clustering behaviour of different GFP-tagged NDP52 
variants. Therefore, SAXS was employed to provide novel insights not only into the 
structure of full-length NDP52 (currently unavailable) but also the dimeric 
arrangement of NDP52 homodimers.  
SEC-MALS has shown previously that NDP52 is homodimeric in solution (Figure 26). 
Therefore, peak 2 of SAXS data (Figure 36A) likely represents the dimeric form of 
NDP52. However, peak 1 (Figure 36A) is at the limit of the SEC column (void volume) 
suggesting that this peak is aggregation of NDP52. This is supported by Guinier fitting, 
where, for peak 1, Rg values are very varied (Figure 36B) suggesting heterogeneity. 
However, Rg values for peak 2 are constant (Figure 36C) suggesting homogeneity and 
that sample preparation is of good quality (can be used for interpretation). Intensity 
plots further support that peak 1 likely corresponds to aggregates and peak 2 the 
NDP52 dimer. For instance, peak 1 is considerably nosier at larger values of q, 
compared to peak 2, where average (black) and median (cyan) values largely agree 
(Figure 37); again, suggesting that peak 2 is homogeneous.  
From the SAXS envelope, the structure of NDP52 is shown to be asymmetrical (Figure 
38D), suggesting that NDP52 likely adopts a parallel homodimeric conformation in 
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vitro (Figure 40C). For instance, if both N-terminal SKICH domains were aligned in the 
anti-parallel configuration, NDP52 would be symmetrical (Figure 40D). An end-to-
end orientation of the dimer (Figure 40E) is also dismissed since you would again 
expect to see symmetry. 
Interestingly, one end of NDP52 is shown to be curved (Figure 38D) but the other 
globular. It is likely that these correspond to the C-terminal double-ZF motif (or LIM-
L domain) and the N-terminal SKICH domain respectively (Figure 40A). This is since 
the SKICH domain is well-characterised as globular (PDB entry – 3VVV). The potential 
curvature of the ZF domain may confer tight binding to DNA, by ‘wrapping around’, 
to enable NDP52 function as a transcriptional regulator.  
SAXS was performed on 3 different gel filtration columns (Shodex KW405-4F, 
Superdex™ 200 increase 3.2/300 and Superose™ 6 increase 3.2/300). However, only 
results from the Superose™ 6 column are shown in this study. Data from the Shodex 
column showed higher heterogeneity of the sample (assessed by Rg values) and 
poorer resolution of peaks 1 and 2, compared to the Superose™ 6 column. Despite 
the lower quality of data from the Shodex column, the SAXS envelope generated 
using this data also (Figure 40B) supports a linear/elongated shape for NDP52. 
Although, one end of the structure (red box; Figure 40B) shows some variation, 
compared to the model generated using the Superose™ 6 column, suggesting that 
this could be another state of this domain (since SAXS envelopes are an average of 
multiple bead models) and hence inferring flexibility. This provides important 
functional insights. For instance, if this flexible region corresponds to the ZF-motif (as 
discussed), the flexibility may confer the ability of the curved structure to wrap 
around DNA and enable tight binding for NDP52’s role in transcription. Similarly, this 
flexibility may be important for NDP52-facilitated unfolding of myosin VI7, as well as 
autophagosome maturation where NDP52 binds both MVI and ubiquitinated targets 
via its tandem ZF motif59,61.  
Interestingly, the central domain of the SAXS envelope shows some globular 
arrangement (Figure 38D). This topology may arise from the LZ or the arrangement 
of the α-helices in the coiled-coil domain of NDP52. Again, this may provide 
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important structure-function insights into the action of NDP52 as a putative 
transcription regulator.7 For instance, this conformation may be essential for docking 
of other proteins or binding to DNA.  
Future work should therefore focus on obtaining higher resolution structures for full-
length NDP52 using techniques such as X-ray crystallography (previously tried but 
unsuccessful79) and NMR. Such efforts to improve our structural knowledge of NDP52 
are currently ongoing in the Toseland laboratory. For instance, cryo-electron 
microscopy (EM) data has been collected and is currently being analysed, which will 
provide a much higher resolution structure of NDP52 compared to SAXS. Higher 
resolution insights are important as SAXS envelopes only give an outline structure 
and are hence limited in the information they provide. For instance, SAXS envelopes 
provide no information regarding the secondary structure and require models, pre-
determined by alternative methods such as X-ray crystallography, to be fitted to 
them. It is therefore important that going forward current crystal and NMR 
structures (for the SKICH and ZF domains respectively) are fitted to the SAXS 
envelope to identify which end represents the N-terminus. However, it is 
acknowledged that it may be difficult to obtain full-length crystal structures for 
NDP52 (as previously observed79) due to the flexibility inferred by SAXS.  
The finding that NDP52 is likely a parallel homodimer is particularly important for 
structure-function observations in relation to transcriptional regulation. For 
instance, the parallel nature of NDP52 may suggest that NDP52 can achieve tighter 
binding with DNA, where NDP52 could clamp down on DNA from both sides. This also 
makes sense due to potential flexibility observed in the NDP52. Whereas, if an anti-
parallel dimeric conformation was inferred, this may suggest that NDP52 acts as a 
linker between DNA and another protein, since residues 120-end have been shown 
(in this study) to bind DNA with high affinity.  
The parallel configuration of NDP52 may also be of functional significance with 
regard to MVI unfolding7. For instance, MVI is a parallel homodimer, with motor 
domains orientated in the same direction to enable hand-over-hand walking along 
actin12. Therefore, the parallel arrangement of NDP52 presumably enables binding 
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to MVI to facilitate unfolding, dimerisation and subsequent binding to DNA for 
transcriptional regulation7.  
Notably, the results from cryogenic super-resolution microscopy (Section 11.8) and 
SAXS starkly contradict each other – one result suggests an anti-parallel arrangement 
while the other parallel. However, the results from SAXS are considered more 
trustworthy, given that superSIL microscopy is currently limited as direct 
measurements cannot yet be made between GFP fluorophores (meaning only 
statements regarding similarities or differences in clustering behaviour can be 
made). The anti-parallel arrangement, suggested by superSIL microscopy, is 
therefore likely to come from NDP52 aggregating under cryogenic conditions, which 
is likely to be an artefact of the sample preparation rather than a true reflection of 
NDP52 clustering since this behaviour is not observed under non-cryogenic 
conditions. 
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Figure 40: Interpretation of SAXS data  
(A) Cartoon representation of NDP52 overlaid onto the SAXS envelope (using the Superose™ 6 increase 3.2/300 column) by eye. (B) Resultant SAXS envelope 
using the Shodex KW405-4F column. Potential flexible domain marked with a red box. NDP52 schematically shown as a parallel (C), anti-parallel (D) or end-
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12 Conclusions 
For the first time, novel methodologies are reported for the purification of full-length 
ERα using the E.coli BL21 stain, where the presence of estradiol in the culture 
medium significantly improves purification results consistent with other studies77,78. 
Although, major problems were identified, including aggregation and degradation. 
However, this methodology provides a robust foundation for further optimisation of 
ERα purification, using the E.coli BL21 strain as an inexpensive and time-efficient 
expression system, required for further biochemical and biophysical characterisation 
of ERα focussing on its interaction with MVI.  
Biochemical assays have elucidated the DNA-binding characteristics of NDP52 
structural domains. These results importantly contribute to our understanding of 
NDP52 as a transcriptional co-activator, as the DNA-binding site has been mapped to 
the coiled-coil domain (inclusive of the LZ), together with the double-ZF motif. This 
domain is therefore likely to be crucial for NDP52’s function as a transcription co-
activator. In the future, mutagenesis of key residues within this structural domain 
can be investigated with regard to dsDNA binding.  
Evidence presented here also provides important insights not only into the tertiary 
structure of NDP52 but also the oligomeric state of the protein. For instance, NDP52 
has been shown to be largely linear in structure, with globular N-terminal domain, 
and to be a homodimer in vitro. For the first time, the conformation of this dimer 
was probed using a recently-developed super-resolution microscope and SAXS. 
Although superSIL requires much optimisation, particularly with regard to data 
analysis, this is a promising technique which could be used in the future to support 
findings from SAXS, which suggest that NDP52 functions as a parallel homodimer in 
vivo. This finding provides important structure-function insights into NDP52’s role in 
transcriptional regulation, where a parallel conformation may enable NDP52 to 
clamp down either side of DNA, enabling tight binding. Future work should be 
centralised on achieving higher resolution structures for full-length NDP52, through 
methods such as X-ray crystallography, cryo-EM and NMR.  
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14 Supplementary Data 












Assuming all Disulphide 
Bonds Present (M-1cm-1) 
Extinction Coefficient 
Assuming all Disulphide 
Bonds Absent (M-1cm-1) 
Human pET151 His-tag* 
ERα (1-end)  ESR1_HUMAN P03372 ERα-His 67,039 62,520 61,770 




190 23,288 30,160 29,910 
Human pET151 His-tag* 
NDP52 (120-end) 
NDP52 
120-end 38,931 13,575 12,950 
Human pET151 His-tag 
GFP-NDP52** (1-end) 
GFP-
NDP52 79,945 65,625 64,750 





106,813 87,640 86,640 
Human pET151 His-tag* 
NDP52 NDP52 53,076 43,610 42,860 
Extinction coefficient and molecular weight estimates taken from ProtParam using the first isoform listed for each entry on UniProt. 
* ‘His-tag’ refers to 6 N-terminal histidine residues  **GFP-tags linked to NDP52 via a 4-glycine linker 
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Figure 41: Positive and negative controls for ds40 NDP52 binding assays 
5μM NDP52 1-190 (A) and NDP52 120-end (B) were titrated against 100nM ss40 to act as 
negative controls. 8μM NDP52 295-end (C) and ZF1 (D) were also titrated against 100nM 







Hannah Reed 123 
 
Figure 42: Positive and negative controls for ds15 NDP52 binding assays  
10μM NDP52 1-190 (A) and NDP52 120-end (B) were titrated against 100nM ss15 to act as 
negative controls. 16μM NDP52 295-end (C) and ZF1 (D) were also titrated against 100nM 
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Figure 43: Analysis of SEC-MALS protein samples at different angles  
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